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ABSTRACT OF THE DISSERTATION
The Role of Ambient Air Pollution on the Occurrence of emphysema
by
Shiva Metghalchi
Doctor of Public Health in Epidemiology
Loma Linda University, Loma Linda, California, 2010
W. Lawrence Beeson, Chairperson

Emphysema is the most common cause of death from respiratory disease in the
United States. Emphysema is most common among people aged 50 and older. Those
with a genetic predisposition to emphysema may experience the onset as early as their
thirties or forties. Men are more likely than women to develop emphysema, but female
cases are increasing as the number of female smokers rises.
In the past few years, etiological and pathogenic research has been carried out in
an attempt to determine the reason for an increase in deaths and other health problems
associated with air pollution, and there have been significant improvements in our
knowledge concerning the effects of air pollution on respiratory disease.
Although chronic obstructive pulmonary disease (COPD) mortality has been
studied extensively in the past 20 years, to our knowledge, the relationship between long
term ambient air pollution (especially PMio and ozone) and incidence of emphysema has
not been reported. This dissertation evaluates associations between incidence of
emphysema and long-term ambient concentrations of PMio and ozone using data from the
Adventist Health and Smog (AHSMOG) study. A cohort of 6,338 non-Hispanic, white
m

California adults, ages 27-95, was followed from 1977 to 2000 for various chronic
disease outcomes including self-reported physician diagnosed emphysema. Monthly
ambient air pollution data were interpolated to zip code centroids according to home and
work location histories and averaged over time. Logistic regression analyses, using the
generalized model (PROC GENMOD in SAS statistical software) were used to evaluate
the association between mean concentration of PMio, and ozone and period incidence of
emphysema adjusting for age, sex, education and pack years of past cigarette smoking.
The results of this study indicate that each 10 pg/m increase in mean
concentration of PMio and each 10 ppb increase in mean concentration of ozone were
associated with increased number of new emphysema cases with OR = 1.23 (95% Cl:
1.06-1.43) and OR =1.48 (95% Cl: 1.06-2.07), respectively, after controlling for packyears of past cigarette smoking, age and educational level. In addition, we observed
significant associations between incidence of emphysema and each 40 day increment of
ambient PMio levels in excess of 40, 60, 80 and 100 pg/m3 and each 10 days average
annual increment of ozone in excess of 100, 120 and 150 ppb. Our findings suggest that
chronic exposure to ambient air pollution is associated with development of emphysema
in adults.
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CHAPTER 1
INTRODUCTION

Chronic obstructive pulmonary disease (COPD) is a chronic incapacitating
condition, with a high level of morbidity, mortality, disability and psychological distress
which significantly impacts the quality of life of individuals1. COPD refers to a group of
conditions that are characterized by “airflow limitation” and can cause shortness of
breath, persistent cough, sputum or mucus production, wheezing, chest tightness,
enlargement of the chest and tiredness. People with advanced COPD may develop
respiratory failure1.
The role of air pollution is becoming increasingly important in the development
and exacerbation of chronic airway disease. Outdoor (ambient) air pollution is primarily
the product of fossil and other organic fuel combustion used for heating, industrial
production and motor vehicles2. The major outdoor air pollutants are suspended
particulates of various sizes including PMio, PM2.5 (fine), and PM0.1 (ultrafmes), SO2,
NO2 and O3 (ozone)2. Brief increases in ambient air pollution initiate temporary
decreases in pulmonary airflow. Chronic ambient air pollution exposure appears to be
related to an increase in the prevalence of lower and upper respiratory symptoms2.
Till just now, COPD was ranked the fourth leading cause of death in US and was
anticipated to go up to be the third leading cause of death globally by 2020 . This
changed just recently when the CDC reported that the disease has moved up 12 years
ahead, and, as of 2008, is now the third leading cause of death in the United States . In
2005, roughly one in 20 deaths in the United States had COPD as the underlying cause4.
1

An estimated 126,500 deaths of persons aged >25 years occurred in 2005 with COPD as
the underlying cause, an increase of 8% from 116,494 deaths in 20004.
In the past two decades, there have been numerous epidemiological studies
ranging from time-series studies to cohort studies examining the effect of air pollution on
human health. The majority of these studies have focused on associations between air
pollution and mortality and morbidity of COPD, mainly asthma5'8, bronchitis6’9’10, lung
function 11-13 and various respiratory symptoms 14-16 such as cough, phlegm and shortness
of breath. However, few, if any, have looked at the effects of air pollution, particularly
PM io and ozone, on development of emphysema. Therefore, the goal of this dissertation
was to examine association between long-term exposure to ambient air pollution and the
development of self- reported doctor diagnosed emphysema among California Adventists
(SDA) during the time period 1977-2000.
To the extent possible, this dissertation evaluates the association between
exposure to ambient air pollution and the development of emphysema independent of
selected possible risk factors. Due to the nature of the data, this dissertation was limited
to examining associations and generating hypotheses. Like any epidemiological study,
the results may have some drawbacks, and are not intended to prove causality, but aimed
to initiate an insight on identifying factors associated with the development of
emphysema.
The following chapter (Chapter 2) consists of a review of the literature on the
related epidemiological features of emphysema and COPD. The next two chapters
(Chapter 3 and 4) contain formatted publishable papers. Chapter 3 presents an evaluation
of the association between long-term exposure to PMio and the development of
2

emphysema. Chapter 4 presents the results from an evaluation of the association between
long-term exposure to ozone and incidence of emphysema. Chapter 5 includes additional
analyses to evaluate whether an association existed between long-term mean
concentrations of ambient PMio and risk of asthma. Finally, Chapter 5 includes a
systematic discussion, suggestions for future research and a conclusion.

3

CHAPTER 2
REVIEW OF THE LITERATURE

A. Introduction
This chapter presents an evaluation of the existing state of knowledge across
diverse epidemiological aspects of chronic obstructive pulmonary disease (COPD).
While limiting this section to a brief overview, selected articles on definition and
background, risk factors, biological plausibility of the role of ambient air pollution on
COPD are summarized. The results documented within this review guided the choice of
variables that were selected for controlling their potential confounding effect in the
analyses which are presented in chapter 3, 4, and 5.
B. Definition
Chronic obstructive pulmonary disease (COPD) is defined as a disease state
characterized by airflow limitation “that is not entirely reversible, but is both preventable
and treatable”. The airflow restriction is typically progressive and associated with an
abnormal inflammatory response of the lungs to toxic particles or gases . The current
definition for airflow limitation is an FEV i ( forced expiratory volume in 1 second) to
FVC ( forced vital capacity) ratio of less than 70%, measured with post-bronchodilator
lung function18. While this "fixed" ratio is easy to remember and simple, there is some
concern that it may underestimate COPD in younger populations, overestimate it in older
ones, and misclassify other patients19.
Even though lung function measurements continue to be important for the
diagnosis of COPD, other factors have emerged as being important predictors of the
4

quality of life and the survival of patients with COPD. Some of these factors include fatfree body mass, functional status, exercise capability, respiratory symptoms, and the
presence of co-morbid diseases, such as heart failure

17,18

. Although these factors have

not been formally part of the definition of COPD, they are obviously important, both
clinically and epidemiologically, and need to be considered in the evaluation of
individuals with COPD.
1. Major Forms of Chronic Obstructive Pulmonary Disease
a. Emphysema is a lifelong, progressive disease of the lung that mainly
causes shortness of breath. It is characterized by destruction of lung tissue around
smaller airways20.
b. Chronic Bronchitis is a type of chronic obstructive pulmonary disease
(COPD) that can be caused by chronic inflammation of the bronchi (medium-size
airways) in the lungs20.
C. Epidemiology of Emphysema (COPD)
COPD is a common and under-diagnosed disease. It is estimated that 210 million
people globally have the disease21. In addition, it is believed that about half of all COPD
cases in the developed countries are not diagnosed21. Data from NHANES III22 indicated
that during 2000, an estimated 10 million adults in the United States reported "physiciandiagnosed COPD". In the USA, for those aged 25-75 years, the estimated prevalence of
mild COPD was 6.9% and of moderate COPD was 6.6%. The prevalence of both mild
and moderate COPD was higher in males than females, in Whites than in Blacks, and
increased steeply with age22. In the NHANES III study, COPD was estimated to be
present in 14.2% of current White male smokers, 6.9% of ex-smokers and 3.3% of never5

smokers. Among White females, the prevalence of airflow limitation was 13.6% in
smokers, 6.8% in ex-smokers and 3.1% in never-smokers23. Less than 50% of
individuals with COPD based on airflow limitation have a doctor’s diagnosis of COPD .
Thus, a major limitation of assessing COPD in epidemiologic studies is that a large
proportion of COPD remains undiagnosed and would not be detected by asking about
doctor diagnosed disease.
Long-term tobacco smoking or other risk factor exposure is necessary to produce
destructive lung disease which indicates that emphysema is mainly a disease of middle
and late adult life. Emphysema is frequently observed earlier in individuals with alantitrypsin deficiency, especially in smokers. Alpha-1 antitrypsin is a protein made in the
liver which protects the lungs and liver. The deficiency is caused by a genetic defect.
The condition is largely widespread among Europeans and North Americans of European
origin. However, a few cases of early onset smoking-related emphysema have been
observed in the absence of a 1-antitrypsin deficiency24. In the past, the prevalence of
COPD has been higher in males; however, the increase in female smokers in the
developed countries has resulted in an equal distribution between the sexes .
Overall, the prevalence of COPD is high and shows an increase in trend with
time26. Several factors contribute to this, including improved medical diagnosis, people’s
increased interest in their health, and absence of an effective cure for COPD, changes in
the environment and life style, or increased life expectancy and increase in the elderly
population26.

6

1.

Morbidity and Comorbidity
COPD is more frequent in developed countries than in developing ones.

In the United States, the disease occurs more often in the White than in the Black
population27. Also COPD is strongly associated with age. Therefore, prevalence and
incidence have increased continuously over the last decades, as the population aged.
During 2006, COPD was the fourth leading cause of death in US, causing 120,970
deaths28. In 2007, 12.1 million U.S. adults were expected to have COPD. Also almost 24
million U.S. adults have evidence of impaired lung function, signifying an under
diagnosis of COPD1.
COPD is also associated with significant co-morbid disease, such as
cardiovascular disease and cancer. In a nationally representative sample of 47 million
hospitalizations from 1979 to 2001, patients discharged from the hospital with a diagnosis
of COPD were more likely to be hospitalized also with pneumonia, hypertension, heart
failure, ischemic heart disease, or pulmonary vascular disease when compared with ageadjusted patients discharged without COPD29. Furthermore, a diagnosis of COPD was
associated with higher age-adjusted in-hospital mortality for pneumonia, hypertension,
heart failure, and thoracic malignancies when compared with patients who were
29

discharged with these comorbidities but did not have a diagnosis of COPD .
Similar findings of co-morbid disease have been replicated in other populations.
In a study of 38 patients with COPD and matched control subjects without COPD, the
prevalence of metabolic syndrome was 47% versus 21%30. When a large UK population
of patients newly diagnosed with COPD was compared to a control population who had
any medical condition including allergies and rhinitis or any other significant disease,
7

except COPD, the incidences of myocardial infarction and angina were nearly doubled in
the COPD population31. In a study done by Di Marco in Italy, COPD patients were
enrolled and their levels of anxiety, depression and dyspnea were assessed using specific
questionnaires. One hundred and fourteen of these were sex- and age-matched to healthy
subjects who were used as the control population. Depression and anxiety were four to
five times more prevalent in the patients with COPD compared with control subjects,
with evidence of a greater differences in women. COPD also seems to be associated with
less muscle mass. In a study of 1,898 patients with COPD identified in a populationbased epidemiologic study in Copenhagen, fat-free body mass was decreased in a large
proportion of patients with COPD (adjusted for age, sex, smoking, and lung function),
and there was evidence of women being disproportionately affected .
2. Mortality
Smoking is estimated to be accountable for at least 75% of COPD deaths.
An estimated 126,005 deaths of persons aged >25 years occurred in the US in 2005 with
COPD as the underlying cause, an increase of 8% from 116,494 deaths in 2000, 5% in
men and 11% in women33. During 2000-2005, COPD was the underlying cause of death
for 718,077 persons overall aged >25 years in the United States. The death rate for
women increased from 2000 to 2005 by 23%. The death rate was higher for men
compared with the rate for women in each year, but the number of deaths was greater for
women 27,34
To decrease the number and rate of COPD deaths, public health programs should
continue to reduce personal exposure to tobacco smoke, including passive smoke

8

exposure, occupational dusts and chemicals, and other indoor and outdoor air pollutants
linked to COPD 27,34
D. Risk Factors and Causes of Emphysema (COPD)
1. Cigarette Smoking
Tobacco smoking represents the most important risk factor for respiratory
diseases and it is the major risk factor for emphysema and chronic bronchitis. In 1977 a
study by Fletcher35 reported decrease in FEVi with smoking. Over the years other
studies have shown that the amount of tobacco smoked is associated with the degree of
emphysema and airflow obstruction 36 37-40 . It is now clear that there are a series of
vulnerabilities that potentially are due to the interaction of a number of genetic and other
environmental factors 41,42
One of the most important studies describing the consequences of tobacco
smoking is the 40-year follow-up on male British doctors 43,44 . Mortality of COPD was
demonstrated to be at least seven times higher in smokers than in nonsmokers. While the
overall mortality rate in nonsmokers aged between 35 and 69 years was 20%, it increased
to 41% among light smokers and to 50% among heavy smokers45. Also some other
studies have confirmed the strong relationship between smoking and death from COPD46'
48

. These studies also reported a clearly higher prevalence of chronic cough and chronic

phlegm in smokers compared to nonsmokers in both sexes. Furthermore, stratifying by
age groups, the increase of respiratory symptoms due to aging was faster in smokers than
in nonsmokers and was most evident in men for chronic cough and chronic phlegm. In
addition to an increased occurrence of respiratory symptoms and diseases, current and
previous smokers also have been found to have lower mean diffusing capacity of carbon
9

monoxide than the never-smokers. With regard to respiratory function, several studies
point out that smokers are at a higher risk of decreased FEV j and report a dose-response
relationship between the intensity of smoking and the decline in FEVi48'52.
2. Occupational Exposure
A higher incidence of emphysema in workers in several occupations is
associated with exposure to fumes, chemicals, and dusts53,54. A study of Norwegian
tunnel workers showed that exposure to dust particles resulted in a decline in FEVi of 2538 ml/yr in non-smoking workers55 and studies in gold miners have reported higher rates
of emphysema in those with long term exposure to underground mineral dust ’ .
Therefore, it is possible that any occupation in which workers are constantly exposed to a
combination of fumes and airborne particles can increase the risk of developing
emphysema among those workers, and this effect is specifically major in those who also
smoke.
3. Socioeconomic Status and Lifestyle
Socioeconomic status may be evaluated by using indicators such as
income, education, type of work and house conditions. A low socioeconomic level is an
independent risk factor for the development of emphysema and chronic bronchitis ’ .
Investigators 59,60 have demonstrated that for bronchitis, emphysema and asthma, the
standardized mortality ratio increased with a decreasing socioeconomic status. An
association between the prevalence of chronic bronchitis and a low socioeconomic status,
even after adjusting for smoking and other risk factors was detected in some studies ’ .

10

4. Gender
In the past, male gender was considered a risk factor for COPD and the
potential explanation was believed to be the higher smoking and occupational exposures
compared to women. However, it has been proposed that women may actually be at
higher risk of developing COPD63. Torres et al.64 and DeMeo et al.65 have demonstrated
that the impacts of smoking on lung function were more severe in females than in males
and they also found a higher risk of hospital admission due to COPD among women than
men when controlling for smoking habits.
Some data demonstrate that genetic interactions may be important to the gender
differences observed in COPD66'68. These data suggest that genes may interact with
smoking and gender-specific factors for the development of emphysema. Also the
National Emphysema Treatment Trial (NETT) subjects have been associated with genetic
variation69. Therefore, future research should concentrate on biological and genetic
factors that may drive gender differences in COPD.
5. Genetic Factors
The most documented genetic association with emphysema is that of a-1
antitrypsin deficiency70. The alpha-1-antitrypsin deficit is due to a hereditary defect of
two alleles of the inhibiting protein positioned in the gene locus of the section of
chromosome 14q32.1. The homozygote phenotype PiZZ has been linked to a severe form
of pulmonary emphysema. Not every homozygote which has a deficit of the inhibiting
protein develops the disease. Smoking appears to considerably increase the risk of
disease in the heterozygote forms71,72. Some other genetic alterations such as alpha-2-

11

macroglobulin, vitamin D binding protein and the blood serotype group genes have also
been associated with a higher risk of developing COPD .
A range of other genes have been involved in the pathogenesis of emphysema.
Hersh has found single nucleotide polymorphisms to be involved with several clinical
characteristics of emphysema, including dyspnea, exercise tolerance, and gas transfer
impairment74. Also gene polymorphisms in glutathione S-transferase pi and matrix
metalloproteinase-1 have been shown to be related to lung diseases and may alter
detoxification of cigarette smoke metabolites69.
6. Family History
A decline in lung function has been related to a familial history of lung
cancer and COPD, suggesting that the impaired lung function may correspond to a
common basis for the effect of cigarette smoking and that diseases linked to smoking
may have a common familial factor 75. Studies suggests that the risk of COPD
development in relatives of smokers or ex-smokers with early-onset COPD is about three
1

77

times higher than that of a control population ’ .
7. Air Pollution
Air pollution has also been implicated in the rising occurrence of asthma,
bronchitis and emphysema. Air pollution acts in a similar manner to cigarette smoke.
The pollutants cause inflammation in the airways, leading to lung tissue destruction. Air
pollution can contain toxic contaminants and volatile organic compounds (VOCs) which
have been released into the air. All over the world, fuel, in the form of oil and coal, is
burned to run factories, machinery and all forms of transportation. The burning of these
fuels creates by-products such as smoke and invisible irritants which contaminate our
12

atmosphere. Many consumer products such as hair spray, paint, cleaners, windshield
washers, etc. release high levels of VOCs into the atmosphere. The cumulative effect of
78

air pollution destroys our environment and poses health threats to humans .
In the past few years, etiological and pathogenic research has been carried out in
an attempt to determine the reason for this increase, and there have been significant
improvements in our knowledge concerning the effects of air pollution on respiratory
disease60’62’79.
Studies conducted over the past 15 years have provided substantial evidence that
long-term exposure to air pollution is a risk factor for cardiopulmonary disease

41,80-88

The new studies confirm earlier research showing positive associations between
prevalence of COPD and ambient concentrations of particulates, especially PMio, as
products of combustion.
In addition to passive smoking, which is well known for its harmful action on
respiratory health, a number of compounds and mixtures have been identified as relevant
air pollutants indoors75. They may be derived from heating, combustion, photochemical
reactions, furniture, building materials, biological organisms and fibers. The main health
effects associated with indoor pollution are respiratory symptoms, lung function
reduction and decline, bronchial hyperresponsiveness and respiratory infections, some of
which are also characteristics of COPD.
E. Air Pollution Sources
1. Ozone
Ozone (O3) is created in the atmosphere by the reaction of organic
hydrocarbon compounds and oxides of nitrogen (e.g. NO, NO2, N2O5, etc.) in the
13

presence of energy from the sun. Variable weather patterns can be accountable for yearly
variation in O3 levels89. Ozone (O3), in the stratosphere (10 to 30 miles above earth),
serves as a protective shield against the sun’s harmful ultraviolet radiation. Ozone in this
portion of the atmosphere is beneficial. However, in the troposphere (0 to 7 miles above
the earth’s surface), the very same compound is harmful, acting as a pollutant with a
multitude of potential associated adverse health effects (premature death, asthma,
bronchitis, heart attack, and other cardiopulmonary problems) 89 .
2. Particulate Matter (PM)
PM includes solid or liquid particles found in the air: pollens, dust, and
aerosols from combustion activities90 as well as meteorological conditions such as wind
blown dust. The chemical and physical structure of particles differs extensively. PM can
be produced directly or can be formed in the atmosphere when gaseous pollutants such as
SO2 and NO2 undergo transformation to form fine particles. The chemical and physical
composition of PM differs based on location, source, time of year, and climate.
Typically, suspended particles in the air are classified into two sizes: those that are 3-30
pm in aerodynamic diameter (coarse mode) tend to be of natural origin and to be
alkaline; those that are < 3 pm in aerodynamic diameter (fine mode) derive largely from
manmade sources and include acid concentrates of combustion processes91,92. The size of
the particle is crucial because particles < 2-3 pm in aerodynamic diameter tend to deposit
deep in the lungs, in the terminal bronchioles and alveoli; larger particles tend to deposit
in the upper airways93.
Overall, directly produced PM comes from two separate sources. The first source
includes fossil fuel combustion, industrial processes, and transportation. The remaining
14

of direct PMio emissions is accounted for by miscellaneous anthropogenic and natural
sources. These include fugitive dust, agriculture and forestry, wind erosion, wildfires,
and managed burning .
3. Sulfur Oxides
Sulfur dioxide (SO2) is one of a group of highly reactive gases known as
oxides of sulfur. The main sources of SO2 emissions are from fossil fuel combustion at
power plants (66%) and other industrial facilities (29%). Less significant sources of SO2
emissions are industrial processes such as extracting metal from ore, and the burning of
high sulfur containing fuels by locomotives, large ships, and off-road equipment. SO2 is
associated with a number of harmful effects on the respiratory system including
bronchoconstriction and increased asthma symptoms94.
The sulfur oxides and PM often have common sources, mainly combustion
processes. It is possible that many of the health effects of SO2 reflect the joint action of
the mixture of pollutant components formed by fossil fuel combustion94.
4. Nitrogen Dioxide
High-temperature ignition processes in motor vehicles, fossil fuel-fired
power plants, and industrial boilers form nitric oxide (NO) and, to a smaller degree, NO2.
NO2 is an oxidizing agent that reacts with the moisture in the air to form nitric acid, and
toxic organic nitrates. In addition, NO2 plays a major role in the atmospheric reactions
that produce O394.
NO is found in motor vehicle exhaust and is quickly oxidized to NO2 when
exposed to the oxygen in the atmosphere. The natural sources for NO2 include lightning
and biologic processes in soil which are minimal compared to anthropogenic sources.
15

The estimates of natural NO production are remarkably influenced by differences in
climate and land use95.
F. Health Impacts
The burden of disease attributable to emphysema is significant and growing, and
is a leading cause of disability in middle and late life. The National Emphysema
Treatment Trial (NETT)96 collected a large amount of follow-up data on this specific
population of patients, with information concerning lung function, symptoms, health
status, exercise capacity, and mortality. NETT reported that COPD patients have an
impaired quality of life, which deteriorates with decline in lung function97 and time98,99.
Mortality was associated with several clinical and physiologic measures. Higher residual
volume (RV) and lower total lung capacity (TEC) were alone predictive of mortality100.
Epidemiologic studies suggest that several factors are required in order to develop
emphysema, even though it is unclear exactly how these factors contribute. Long-term
tobacco smoking could produce serious lung disease. Emphysema is frequently observed
earlier in a 1-antitrypsin deficiency, especially in those who also smoke. However, few
cases of early onset smoking-related disease in the absence of a 1-antitrypsin deficiency
are observed24. As emphysema comes under the umbrella of COPD, there is limited
information on the emphysema as such. Therefore, this review will focus on
summarizing studies about COPD.
1. Time-Series Studies
There are a considerable number of time-series studies on the short-term
health impacts of air pollution, with the majority focusing on mortality and hospital
admissions at a community level or ecological level. This type of time-series design has
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been a major method for evaluating short-term health effects of air pollution in
epidemiological studies for the last two decades. Many studies have found associations
between daily variation in ambient particulate air pollution and increased respiratory
hospital admissions 101-104 , respiratory mortality 105-107 and all cause mortality

1 AO

*

. Single-

site time-series studies have been criticized because of exposure measurement errors,
significant variation of the air pollution impacts and the heterogeneity of the statistical
methods used in different studies109. Lately, several multi-site time-series studies have
been carried out in Europe and the United States. Two large air pollution projects in
Europe and U.S. are reviewed below.
In Europe, the APHEA (Air Pollution and Health: a European Approach) studies
have produced many new insights. Initial studies were established on older data
(APHEA-1)110 and a new series of studies (APHEA-2) used data of the PM 10 fraction
since the late 1990s111. The APHEA-2 mortality studies included over 43 million people
and 29 European cities, which were all studied for more than 5 years in the 1990s. The
combined effect estimate showed that all-cause daily mortality increased by 0.6% for
each 10 pg/m3 increase in PM10 from data involving 21 cities. It was observed that there
was heterogeneity between cities with various levels of NO2. The observed increase in
daily mortality for an increase of 1 pg/m3 in PMiowas 0.2% and 0.8% in areas with low
and high average NO2, respectively112. The APHEA-2 hospital admission study reported
an increase of 1.0% per 10 pg/m3 PM10 increment among people older than 65 years for
asthma and chronic obstructive pulmonary disease11 .
In the United States, the National Morbidity, Mortality and Air Pollution Studies
(NMMAPS) studied 20 metropolitan areas during 1987-94113. They reported 0.5%
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increase in all-cause mortality for each increase of lOjag/m3 in PMio. Also, the
NMMAPS data were used to investigate the relation between ozone concentration and
mortality. The result showed that a 10-ppb increase in the previous week's ozone was
associated with a 0.5% increase in daily mortality and a 0.64% increase in respiratory
mortality114. In addition, a recent study showed that short-term exposure significantly
increases the risk for hospital admission for respiratory and cardiovascular diseases109.
While time-series studies have observed that daily variations in air pollutant
concentration are linked to daily deaths and hospital admissions, it is still not evident how
many days, weeks or months of air pollution have caused such events. In addition, some
cases may occur only in those to whom it would have happened in a few days anyhow115.
If so, the increase in cases right after exposure would be offset by a shortfall in daily
deaths a few days later 115,116 . If air pollution has this impact, normal time-series models
are unable to evaluate the outcomes because of the issues of collinearity and statistical
power.
2. Case-Crossover Studies
Case-crossover study design is another method for estimating short-term
health effects of air pollution in epidemiological studies. In the last two decades, the case•
•
117 120
crossover design has been utilized in many air pollution
and health studies
' .For

example, Sauerzapf et al.117 used a case-crossover study design to examine the relation
between air pollution and hospital admissions for COPD and discovered that higher
levels of ambient air pollutants were positively associated with increased daily hospital
admission. Several other case-crossover studies evaluated the association between air
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pollution and hospital admissions and reported positive associations between exposure to
air pollution and increased hospital admissions 118-120
3. Panel Studies
Many air pollution panel studies such as the Southern California
Children's Health Study 121,122 found that exposure to ambient particles and NO2 was
associated with decreased lung function in children. Another large panel study, the
Pollution Effects on Asthmatic Children in Europe (PEACE), evaluated the relationship
between short-term variation in air pollution and lung function, respiratory symptoms and
medication use123. The PEACE study found no association between changes in PM 10, SO2
and NO2 and respiratory health. This might be due to the short observation period. Ward
and Ayres124 reviewed 22 panel studies that evaluated the total effects of ambient
particles on children. Results show that the majority of panel studies suggested an
adverse effect of particulate air pollution. Several recent panel studies also demonstrate a
negative association between air pollution and lung function 12,123-127
4. Cohort Studies
There are only a few large cohort studies compared to many time-series and casecrossover studies. About a dozen cohort studies have been carried out in the United States 87,128-130
• •
87
and Europe 131-135 . Three large American cohort studies, the Harvard Six Cities Study , the

American Cancer Society Study 136,137 , and the Adventist Health and Smog Study
(AHSMOG) 13,128,138-142 have shown an increased risk for general, cardiopulmonary and cancer
mortality associated with ambient air pollution.
Four cohort studies have proposed that extended exposure to air pollution is
accountable for increases in mortality rates in the long term. Two American cohort
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studies, the Harvard Six Cities Study87,136 and the American Cancer Society (ACS)
Study85 demonstrated an association between the mean levels of pollutants during the
study period and the probability of death. A third American cohort study (the AHSMOG
Study) confirmed the results of the previous studies. This cohort consisted of relatively
old non-smoking subjects, with the mean age at inclusion being 58.5 years for the men
and 59.2 years for the women. The authors found an association between PMjo and
mortality from nonmalignant respiratory disease in both sexes128 and the risk of death
from lung cancer in both sexes but with a more marked effect in men than in women141.
The AHSMOG study13 also showed that an increase in mean concentration of SO4
of 1.6 pg/m3 was related to a 1.5% decrement in FEV) in all males. A raise of 23 ppb of
ozone 8-hr. average was associated with a 6.3% decrement in FEVi in males whose
parents had asthma, bronchitis, emphysema or hay fever13. These data demonstrated that
prolonged exposure to ambient ozone is related to development of asthma and other
respiratory conditions in adult males. In addition, the ASHMOG study demonstrated that
prolonged exposure to ambient concentrations of PM10 from 1973 to 1992 and other air
pollutants (total suspended sulfates, sulfur dioxide, ozone (O3), and nitrogen dioxide)
were associated with 1977-1992 mortality in a cohort of 6,338 nonsmoking California
Seventh-day Adventists128.
Hoek et al. investigated a random sample of 5000 people where 489 of 4492
(11%) died during 1986-1994 in the Netherlands and observed that cardiopulmonary
mortality was associated with living near a major road with a relative risk of 1.95 (95%
Cl: 1.09-3.52)134. A cohort study conducted by Filleul et al. in France found urban air
pollution to be associated with increased mortality over 25 years in France132. Frostad et
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al., in a 30-year follow-up cohort study in Norway, showed that respiratory symptoms
significantly predict mortality from all causes133. After 11 years of follow-up, the
SAPALDIA135 study recently reported that improvements in air quality were associated
with declines of FEV] and FEVi/FVC. A drop of 10 pg/m3 PMio over 11 years of
follow-up slowed the decline in FEVi by 9%. In this study PMjo levels were modeled for
each region for the complete follow- up period and overall, pollution declined during
follow-up.
G. Summary
COPD is a common disease causing a great deal of morbidity and mortality both
in the United States and worldwide. Population aging is not the only cause of the
increased prevalence of COPD observed over the last decades, but other risk factors must
be taken into account. The smoking of tobacco is the most important cause. Work
exposure to toxic agents and air pollution represent other causes of the development of
COPD, which may also be decreased by adequate measures of individual and collective
prevention.
A number of studies have demonstrated that exposure to air pollution is harmful
to human health. Various areas of research have helped link some of the important gaps
in our knowledge. Different studies using a variety of methods, including time series and
case-crossover designs, continue to detect consistent associations between
cardiopulmonary mortality and morbidity and exposure to air pollution.
Many time-series, case-crossover and panel studies have constantly demonstrated
that there are short-term effects of air pollution on health outcomes (hospital admissions
or deaths). Some cohort studies have also revealed long-term health effects of air
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pollution. Irrespective of the weak associations of air pollution with human morbidity or
mortality, its public health implications are strong because exposure to air pollution is
universal and widespread. Nevertheless, there are several key methodological challenges
in the assessment of the health effects of low-level exposure to air pollution, such as the
shape of the exposure response curve 143, threshold of air pollution, interactive effects of
air pollution and weather conditions, and model uncertainty and potential bias 144,145
Future research efforts should focus on these important issues.
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CHAPTER 3
FIRST PUBLISHABLE PAPER

Long-Term Ambient PMjo Concentrations and Incidence of Emphysema in
Population of California Adults

Manuscript I, entitled “Long-Term Ambient PM i0 Concentrations and Incidence
of Emphysema in Population of California Adults” is prepared to describe the association
between prevalence of self-reported emphysema and PMio mean concentrations in the
Adventist Health and Smog study. The variables included for analysis include
emphysema as an outcome variable and age, gender, education and smoke pack years as
possible confounders. Logistic regression analysis using generalized model (GENMOD)
was performed to ascertain effect measure estimates.
The abstract was accepted in European Respiratory Society 2010 Annual
Congress, Abstract 2310 and in American College of Epidemiology, 2010, ACE-D-1000003. The article is in preparation to be submitted to a journal soon.

For Submission to: Chest Journal
*Note: The format and referencing style of this chapter is in accordance with journal
formatting guidelines as required by journal specifications and is not in accordance with
dissertation guidelines.
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ABSTRACT
The aim of this study was to assess the relationship between long-term
concentrations of ambient PMio and risk of emphysema in California adults. A cohort of
6,338 non-Hispanic, white Californian adults, ages 27-95, was followed from 1977 to
2000 for various chronic disease outcomes including physician diagnosed emphysema.
Monthly ambient air pollution data were interpolated to zip code centroids according to
home and work location histories and averaged over time. A significant association
between mean concentration of PM io and incidence of emphysema was observed in
females with an OR of 1.37 (95% Cl: 1.11-1.69) for each increase of 10 jag/m3 in mean
PM io after controlling for pack-years of past cigarette smoking, age and educational level.
In addition, we observed significant positive associations between incidence of
emphysema and each 40 day increment of ambient PMio levels in excess of 40, 60, 80
and 100 pg/m in females. For males, we observed a significant association only between
mean concentration of NO2 and incidence of emphysema. Our findings suggest that
chronic exposure to ambient air pollution is associated with development of emphysema
in adults after adjusting for risk factors like cigarette smoking.

Key words: Ambient air pollution, emphysema, asthma, chronic obstructive pulmonary
diseases, COPD, particulate matter, ozone, sulfur dioxide, nitrogen dioxide.
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INTRODUCTION
Evidence suggests that chronic obstructive pulmonary diseases (COPD) have
become more common worldwide in recent years 1. Some of the risk factors for COPD
are well-known and include: smoking, occupational exposures, air pollution, asthma, and
certain genetic variations, although many questions, such as why < 20% of smokers
develop significant airway obstruction1, remain. COPD is a nonspecific term referring to
a set of conditions that develop gradually as a result of a number of different disease
processes; it most frequently refers to patients with chronic bronchitis and emphysema
and to patients with asthma146,3.
The large number of deaths and other health problems associated with particulate
air pollution was first demonstrated in the early 1970s26 and has been reproduced many
times since. Particulate matter (PM) is one of the main components of air pollution which
can have numerous adverse health effects. PM pollution is estimated to cause 22,00052,000 deaths per year in the United States alone 26,147
In the past few years, etiological and pathogenic research has been carried out in
an attempt to determine the reason for an increase in deaths and other health problems
associated with air pollution, and there have been significant improvements in our
knowledge concerning the effects of air pollution on respiratory disease

2,128,137,148,149

Studies conducted over the past 15 years have provided substantial evidence that
long-term exposure to air pollution is a risk factor for cardiopulmonary disease
13,16,87,128,150

. The new studies confirm earlier research showing positive associations

between incidence of cardiopulmonary disease and ambient concentrations of particulates
(PMio) as products of combustion

5, 7, 151-153
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Although COPD mortality has been studied extensively in the past 20 years, to
our knowledge, the relationship between long-term ambient air pollution (especially
PMio) and incidence of emphysema has not been reported. The purpose of this paper is to
study associations between incidence of emphysema and long-term ambient
concentrations of PMio.
METHODS
Population
The enrollment and follow-up of the Adventist Health and Smog (AHSMOG)
cohort has been described in detail previously154 . In summary, this is a cohort of 6,638
non-Hispanic adult white California Adventists who were part of the larger Adventist
Health Study (AHS-1) cohort155. To be included in the current study, subjects must: (a)
have been residing for at least 10 years within 5 miles of their 1977 residence; and (b) be
a resident of one of three metropolitan areas-San Francisco, the South Coast Air Basin,
(i.e. Los Angeles and eastward), or San Diego or be part of a 13% random sample of
AHS-1 subjects who lived in the remainder of California; (c) be at least 25 years of age at
the time of completing the Adventist Census Questionnaire in 1974; (c) not currently
smoking at the time of baseline enrollment; and (d) be a baptized member of the SeventhDay Adventist (SDA) church at the time of enrollment into the Adventist Health
Study 140,154,156
Questionnaire
As part of the enrollment into the AHS-1, the AHSMOG participants completed a
detailed lifestyle questionnaire in 1976 consisting of demographics, anthropometries data,
exercise patterns, alcohol and tobacco consumption, occupation, current and past dietary
26

habits, parental history of cancer, and history of selected medical conditions

139,155,156

. In

1977, 1987, 1992 and 2000 the AHSMOG subjects completed mailed questionnaires
which included standardized respiratory symptoms questions derived from the American
Thoracic Society questionnaire154. In addition, based on these questionnaires, residence
and work address histories were updated for the time period 1966 to 2000 or until date of
death. The questionnaires also included lifestyle and housing characteristics relevant to
exposure to ambient air pollutants and indoor sources of air pollutants. For deceased
subjects, information was obtained from surrogates by interviews (usually telephone).
Air Pollution Estimates
Fixed site monitoring stations maintained by the California Air Resources Board
were utilized to estimate the monthly ambient concentrations of ozone (O3), sulfur
dioxide (SO2), and nitrogen dioxide (NO2) for study participants for the period 19732000.

PM10 was not monitored directly in California until 1987. Thus, site- and season-

specific regression equations based on total suspended particulates (TSP) were used to
estimate concentrations of PM10 prior to 1987 l54. The specific methods for estimating
ambient air pollutants for study subjects have been reported previously 140,139,156. Briefly,
monthly indices of ambient air pollutant concentrations at 348 monitoring stations
throughout California were interpolated to zip code centroids based on home and work
location histories of study subjects, cumulated, and then averaged over time.
Interpolations were restricted to zip code centroids within 50 km (31.25 miles) of
a monitoring station and were not allowed to cross barriers to airflow or other topographic
obstructions in excess of 250m above the surrounding terrain156. In addition to mean
concentrations, concentrations in excess of several cutoffs were estimated for PM 10 128
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Exceedance frequencies were defined as the sum of days per year above a specified cutoff
of PM 10. The cutoffs used for PM 10 were 40, 60, 80, and 100pg/m3.
Definition of Health Outcomes
Study subjects were classified as having been diagnosed with emphysema if the
participants reported that they had been told by their physician that they had a diagnosis
of emphysema. Assessment of emphysema was done at the time of each of the mailed
questionnaires in 1977, 1987, 1992 and 2000.
Those who reported having a doctor told diagnosis of emphysema at baseline in
1977 were considered prevalent cases and excluded from this analysis. Participants were
considered as new cases if they did not report prevalent emphysema in 1977, but
indicated a doctor told emphysema diagnosis on any of the subsequent questionnaires in
1987, 1992 or 2000.
STATISTICAL ANALYSIS
Chi-square analysis was utilized to test the difference between baseline
demographic, personal and family characteristics of the cases and non-cases. The
Pearson correlation coefficient was used to measure the association between air
pollutants. Logistic regression analyses, using the generalized model (PROC GENMOD
in S AS statistical software), were used to evaluate the association between mean
concentration of PMjq, NO2, SO2 and ozone and period incidence of emphysema as well
as to assess the association between exceedance frequencies of PM 10 and the incidence of
emphysema. Type III Generalized Estimating Equations (GEE) were used to estimate the
Wald statistic, and hence statistical significance for each explanatory variable.
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Associations between selected pollutants (PMjo, SOi, O3 and NO2) and incidence of
emphysema were examined using both single and two-pollutant models.
Overall average annual mean ambient pollutant concentrations were utilized as
fixed measures of ambient air pollution exposure: 1973-1977 for emphysema cases
identified between 1977 and 1987; 1977-1987 for emphysema cases identified between
1987 and 1992; 1987-1992 for emphysema cases identified between 1992 and 2000.
The non-case comparison groups also were from the same respective time periods.
The incidence of emphysema (1977-2000) was the dependent variable. The air
pollutants were initially studied one at a time controlling for selected variables in a basic
model which included age at baseline, gender, education and pack-years of cigarette
smoking. Based on our research and review of the literature

13,137,146,150,157-161

, the

following additional variables were considered as potential covariates in the development
of the final statistical models: body mass index (BMI), history of allergies, total
exercise, number of homes within 1/4 mile radius of residence in 1977, outdoor vigorous
exercise (hours per week, including weekend), heavy physical labor, time spent outdoors
(hours per week, including weekend), years worked with a smoker, years lived with a
smoker, occupation with significant exposure to air pollutants, fruit intake, alcohol
consumption, vegetarian dietary pattern and antioxidant intake which could potentially
predict incidence or could act as effect modifiers of the emphysema incidence and PM 10
relationship. Any factor whose inclusion changed the main effect of PM 10 for
emphysema by 10% or more was retained as a covariate in the final model. None of the
potential covariates other than those in the final model changed the main effect by 10%
or more. Thus, the final model ultimately used to assess risk of emphysema included age,
29

gender, education and pack-years of past cigarette smoking as well as the pollutant under
investigation. Possible interactions were evaluated between the PMio, SO2, NO2, and O3
and outdoor exposure variables 128,157 with all covariates (age, gender, education, smoke
pack years) included in the final model. Only the gender interaction term significantly
(p<0.05) improved the fit of the model.
Since air pollution components often appear together and are significantly
correlated and the association observed with PM10 could be modified by other air
pollution components, we performed two-pollutant analyses where all pairwise
comparisons of mean concentrations of PM10 with SO2, NO2 and O3 were built-into the
GENMOD models. Pairwise comparisons were made on the fraction of the cohort
having at least 80% non-missing data for both pollutants. In addition, two-pollutant
analyses were also performed for exceedance frequencies of PM10 (40 days/year in excess
of 40, 60, 80 andlOO pg/m3) paired with mean concentrations of SO2, NO2 and O3.
Sensitivity analysis was conducted to further evaluate association between PM 10 and
incidence of emphysema by gender.
RESULTS
Selected characteristics of the study population and incident emphysema cases are
described in Table 3.1. Sixty percent of the cohort lived in the South Coast Air Basin in
1977. Their ages in 1977 ranged from 27 to 95 years (mean= 56.2). Compared to the
non-cases, emphysema cases tended to be older, have lower educational levels, higher
BMI and higher proportion with a history of working in dusty environments and
increased number of hours of vigorous exercise and physical labor outdoors in the
summer.
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There were total of 94 cases of emphysema. Of 94 emphysema cases 51% were
females and 49% were males. Higher proportion of females cases (71%) than female non
cases were nonsmokers with no history of past cigarette smoking. Estimated mean
exposure to PMio was higher for female cases (65.01±12.76) than female non cases
(52.95±16.95). Also higher proportion of males cases (52%) were nonsmokers with no
history of past cigarette smoking. The estimated mean exposure to PMjo for male cases
was 58.20 ±17.38 as opposed to 54.02 ±17.42 for male non cases.
Single-Pollutant Models
Mean concentrations of PMio and O3 were associated with increased odds of
developing emphysema with an OR of 1.23 (95% Cl: 1.06-1.43) and 1.48 (95% Cl: 1.062.07), respectively, controlling for pack-years of past cigarette smoking, age, gender and
educational level (Table 3.2).
When examining the effect of various levels of PMio using exceedance
frequencies, significant associations between incidence of emphysema and each
increment of 40 days/year that PMio exceeded 40, 60, 80 and 100pg/m3 (Table 3.3) were
found. The regression coefficients (and thus OR’s) increased with higher cutoffs of PMio
exceedance frequencies, suggesting a “dose-response” effect (Table 3.3).
Two-Pollutant Models
Compared to the single pollutant models, the PMio associated OR in 2 pollutant
models for emphysema remained virtually the same as in the single pollutant model (3.2).
Likewise, the OR of PM 10 exceedance frequencies (40 days/year in excess of 40, 60, 80
and 100 pg/m3) did not change significantly when the gases were included in the model
one at a time.
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Gender-Specific Models
Since the gender interaction term was significant, sensitivity analysis was
conducted using gender specific analyses. This showed that the association between
mean concentration of PM 10 and incidence of emphysema was limited to females with an
OR of 1.37 (95% Cl: 1.11-1.69) for each increase of 10 pg/m3 in mean PMioas well as a
significant association with exceedance frequencies of PMjo (40 days/year in excess of
40, 60, 80 andlOO pg/m3) (Table 3.5). In addition, a significant association between
mean concentration of ozone and incidence of emphysema was observed in females
(Table 3.2). These gender-specific point estimates did not change significantly when
SO2, NO2 and O3 were added to the models one at a time. For males, no association was
observed between mean concentration of PM10, O3, and SO2 and incidence of
emphysema. Nor was there an association with exceedance frequencies of PMjo in males.
However, we observed a significant association between mean concentration of NO2 and
incidence of emphysema in males (Table 3.2).
DISCUSSION
In this study, we have found long-term ambient concentrations of PM 10 to be
related to development of emphysema in the longer follow-up of the AHSMOG cohort.
Our findings confirm previous findings from this cohort, with shorter follow-up, of
associations between PM 10 and total suspended particles (TSP) and prevalence or
incidence of AOD (asthma, chronic bronchitis or emphysema) 139,140 as well as
development of definite symptoms of overall airway obstructive disease, chronic
productive cough, and increased severity of airway obstructive disease and asthma
prevalence of "definite" COPD154 and decrements in lung function13.
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Risk of emphysema was also associated with each increment of 40 days/year in
excess of various exceedance frequencies of PMio (40, 60, 80 and 100 pg/m ). These
findings are in line with previous reports of an association between exceedance
frequencies of PMio above 100pg/m3 and development of airway obstructive disease,
productive cough, and asthma

.

In our review of the literature, we did not identify any published reports that
specifically addressed the long-term effects of ambient PMio and development of
emphysema. In fact, most studies have mainly looked at effect of long-term ambient
PMio concentrations and all cause mortality and/or prevalence of COPD, asthma,
bronchitis or chronic cough independently as outcomes of interest. However, in the past
20 years both long-term 87,152,139,159 and short-term studies

82, 112,111

have demonstrated that

both acute and chronic exposure to respirable particulates are associated with increased
mortality and morbidity from a number of causes, including chronic obstructive
pulmonary disease and other chronic lung diseases. Our findings of an association
between long-term ambient concentration of PMio and incidence of emphysema are
consistent with these studies.
We found a positive relationship between PMio and development of emphysema
after adjusting for risk factors like past cigarette smoking. This is consistent with other
studies which have looked at a broader category of respiratory diseases including COPD,
chronic bronchitis, and emphysema 162-165 . Similar to our findings regarding emphysema,
other studies have demonstrated that high levels of ambient particles were associated with
increased incidence of chronic bronchitis6,9,166. More recent studies largely show
association between long-term effects of ambient particles and respiratory
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symptoms 76,77,149,167,168 . SAPALDIA, a large cross-sectional population-based study
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reported a 3.4% reduction in forced vital capacity (FVC) perlO pg/m increase in PMjo.
In addition to reduced lung function, the SAPALDIA study also found an association
between respiratory symptoms and annual mean concentrations of NO2, TSP and PMio16.
In Hong Kong, a prospective cohort study found that the prevalence of most respiratory
symptoms increased over a 12-year period after adjusting the data for age, sex, social
status and smoking habits170. This study compared the symptoms between 1991 and
2003 and found that wheeze over the past 12 months increased from 7.5 to 12.1% (OR
2.00, 95% Cl: 1.54-2.61) and morning chest tightness from 4.2 to 8.8% (OR 2.48, 95%
Cl: 1.79-3.43). Also the study reported that the prevalence of self-reported physiciandiagnosed emphysema increased over time (OR 1.78, 95% Cl: 1.12-2.86), but no change
for asthma or for chronic bronchitis was observed.
The AHSMOG Study

also found an association between ambient PM 10 and

long-term risk of death from nonmalignant respiratory disease RR 1.18, (95% Cl 1.021.36) in gender combined analyses and also an increased risk of death from lung
cancer141 (RR 2.38, 95% Cl: 1.42- 3.97), but with a more noticeable effect in men than in
women. A Dutch study134 showed a significant association between cardiopulmonary
mortality rates and living close to a major road (RR 1.95, 95% Cl: 1.09-3.52). There have
been many studies on the short-term effects of air pollution on mortality and hospital
admissions. In Europe, the APHEA-2 (Air Pollution and Health: a European Approach)
Study showed that all-cause daily mortality increased by 0-6% (95% Cl: 0-4-0-8) for
each 10pg/m3 increase in PMiq112. The APHEA-2 Study 111 also demonstrated that
hospital admissions for asthma and chronic obstructive pulmonary disease (COPD)
34
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among people older than 65 years were increased by 1-0% (0-4-1-5) per 10 pg/m
increment in mean PMio. In the USA, the National Mortality, Morbidity and Air
Pollution Studies (NMMAPS) showed that a lOpg/m3 increase in PM via daily time
series analysis was related to a 0.17% increase in respiratory and cardiovascular
•

mortality
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Overall, the results from our study are in line with previous epidemiological
studies supporting a positive adverse effect of exposure to PMio on respiratory health.
Gender Differences
In our study, the association between mean concentration of PMio and
emphysema was observed only in females. Several other studies have also reported
stronger effects of air pollution among women. The Atherosclerosis Risk in Communities
(ARIC) study172 found an association between living near a major road and lower forced
expiratory volume in 1 sec (FEVi ) and forced vital capacity (FVC) only among women.
The authors proposed that the observed gender difference could be due to women’s
greater airway reactivity. A large population-based study of 130,000 respiratory deaths
in 27 U.S. communities found women more susceptible to the chronic effects of air
pollution (e.g. PM2.5) than men. The authors proposed sex-differing respiratory anatomy
and physiology, or different PM deposition patterns173. The Public Health and Air
Pollution in Asia (PAPA) study found stronger associations between PMio, SO2, NO2,
ozone and daily respiratory mortality among women174. The European Community
Health Survey study found home traffic intensity and outdoor NO2 to be risk factors for
chronic bronchitis only among women. The authors proposed sex differences in hormonal
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status, and gender differences in exposures and disease perception as possible
explanations9.
Other possible explanations for gender difference in response to ambient air
pollution could be differences in organ growth and development as well as in the
maturation of the immune system. Females have smaller lungs and a higher level of
bronchial hyper-responsiveness which may make females more susceptible to the impact
of ambient air pollution

1 7S

.

Epidemiological data have demonstrated that there are gender differences in the
susceptibility to the action of air pollution. The effects seem to vary according to the type
of pollutant Young females are at higher risk than young males for an increased rate of
respiratory symptoms, a diminished level of lung function and a higher asthma
medication use due to air pollution 64,174,176,177
Gender is partially responsible for differences in environmental exposures, which
may be crucial in the case of air pollution175. Because work and leisure activities and
domestic exposures differ between females and males, females may be more exposed
than males to some hazards (e.g. nitrogen dioxide, hygiene/cosmetic products, indoor
exposures, cleaning) 64,178 . Differences in the susceptibility to air pollution identified
between females and males could thus be the result of the interaction of genetic,
biological and sociocultural factors, but they are difficult to study 64. For instance, diet,
tobacco and alcohol consumption differ between females and males, because of
sociocultural factors, and exposure. In this study, we were able to control for these, but
the gender difference remained.
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In spite of the growing research on gender differences in the development of
diseases having raised hypotheses on the related mechanisms, the precise role played by
air pollution on these mechanisms still needs more exploration.
Possible Biologic Mechanisms
The biological mechanisms behind associations between ambient PM levels and
incidence of chronic respiratory diseases are not fully understood, but the results of in
vitro toxicological research have shown that PM induces several types of adverse cellular
effects, including cytotoxicity, mutagenicity, DNA damage and stimulation of
proinflammatory cytokine production

179,180

The in vivo and in vitro animal experiments suggest that the mechanisms of the
pro-inflammatory effects of PM 10 involve oxidative stress, upregulation of transcription
factors and pro-inflammatory gene expression 18 ^ The oxidative stress is generated
directly from the ultrafine and transition metal component of PM 10 and indirectly from
the recruitment to the airspaces and activation of blood leukocytes. Oxidative stress is
considered to be a fundamental factor in the generation of inflammation through redox
sensitive transcription factors in COPD

181,182

. Because road traffic is an important

source of PM emission, traffic density has an important impact on both quantitative and
qualitative aspects of ambient PM, including its chemical, physical and toxicological
characteristics.
Potential mechanisms for promotion of emphysema may possibly include
impairment of tissue repair162, prolonged mucous clearance and impairment of alveolar
function71,183'185. Particulate matter may also cause calcium changes in macrophages and
epithelial cells that could be important in priming and activating cells for inflammation
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Strengths and Limitations of the Study
This study has several strengths including a homogenous population of nonsmokers, thus eliminating the effect of residual confounding by active smoking. Also, we
have information on exposure to second-hand smoke and past smoking making it possible
to control for these as well. The fact that the study is a prospective study with complete
history of residence and work location throughout the follow-up increases the validity of
the ambient air pollution estimates for the individual subjects. Also, the subjects were
selected because they were less mobile and had lived within 5 miles of their 1977
baseline address since 1967. This also assures better ambient air pollution estimates and
also makes it easier to follow up this less mobile population.
Although we have shown respiratory effects of particulate air pollution in this
study, we have unknown amounts of measurement error in both the estimated long-term
ambient concentrations of pollutants and other covariates. One source of measurement
error could be interpolating ambient concentrations (PMio, O3, NO2, SO2) from fixed site
monitoring stations to zip code centroids of study subjects’ work and residence
locations156. Another source of measurement error is using indirect estimates of PM10
before 1987. However, a previous study of this cohort has shown that using these
indirect estimates only marginally impacts the precision of long term cumulative
averages of PMio139 .
Another limitation of evaluating the relation between long-term PMio
concentrations and development of emphysema is that our estimates are not of personal
exposures but outdoor ambient concentrations based on data from regional monitors 128,
139

. We have attempted to control for the lack of personal air pollution exposure
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measurements by using self-reported personal exposure to past personal smoking, passive
smoking, occupational exposures to dusts and fumes, as covariates in the health effects
models.
In addition, because the outcome data are self-reported, study subjects may
underreport or overreport respiratory symptoms and diseases. However, this would most
likely be non-differential resulting in an underestimation of the true association. Despite
this possibility, we still found significant associations between exposure to PMio and selfreported emphysema.
SUMMARY
Our results indicate that long-term exposure to ambient PMio is associated with
increased incidence of emphysema in females, but not in males. The association
remained after adjusting for relevant confounders, including pack-years of smoking, and
after adjusting for O3 in two-pollutant models. Further, a significant positive association
was found between incidence of emphysema and each increment of 40 days/year that
PMio exceeded several cutoff points. The PMio regression estimates increased as the
cutoffs increased.
Our findings of a gender difference in the association between ambient air
pollution and respiratory disease are in agreement with those from other studies. Further
research from larger cohorts and with better assessment of exposure and outcome are
needed to better understand the association between PM 10 and incidence of emphysema
as well as the gender difference observed.
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Table 3.1 Distributions of Selected Variables in the AHSMOG Study According
to Noncases and Cases of Incident Emphysema
Emphysema
Variables
Age in 1977 **
< 25-50 Years Old
50-59 Years Old
60-69 Years Old
70 or Older
Gender
Females
Males
BMI
<25 kg/m2
25.0-29.9 kg/m2
>=30 kg/m2
Education
High School Diploma or Less
Some College
College/ Graduate Degree
Diet
Vegetarian t
Non-vegetarian
Current alcohol use
No
Yes
Multi vitamin & vitamin A, C and E supplement
No high vitamin intake
High on at least one of the
vitamin pills
Total exercise
None or light exercise
Mild
Moderate
Vigorous
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Cases
(n = 94)

Non-cases
(n =6246)

%

%

14.0
29.0
39.8
17.2

26.0
25.2
25.4

51.0
49.0

64.0
36.0

54.1
30.6
15.3

58.4
31.3
10.3

40.9
41.9
17.2

35.2
39.0
25.8

57.0
43.0

51.7
48.3

87.9
12.1

92.0
8.0

52.7
45.2

51.0

27.2

13.0
16.3
43.5

23.4

44.2

29.6
11.3
20.5
38.6

Table 3.1 (Continued) Distributions of Selected Variables in the AHSMOG Study
According to Noncases and Cases of Incident Emphysema

Cases
(n = 94)

Variables
Allergies
None/Not Reported
Reported
Job Air pollution *
No
Yes
No. of homes within % radius of residence
<5
5-10
> 10
Hours vigorous exercise & physical labor
outdoors in summer
None
1-14 hours/Week
>=15 hours/Week
Hours outdoor in summer
None
1-14 hours/Week
>=15 hours/Week
Smoke pack years **
Never
1-20 Pack Years
>=21 Pack Years

Emphysema
Non-cases
(n =6246)

%

%

51.1
48.9

56.5
43.5

89.2
10.8

94.5
5.5

3.3

5.5
91.2

4.1
10.1
85.8

25.0
63.0
12.0

22.3
70.7
7.0

1.1
77.2

2.5
77.1

21.7

20.4

28.1
25.0
46.9

44.7
34.2

*/?-Value for chi-square test comparing distributions of cases to noncases <0.05
**/?-Value for chi-square test comparing distributions of cases to noncases <0.01
t
Vegetarian if meat intake none or < 1 time/week. Non-vegetarian, if meat intake >=l/week
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Table 3.2 Multivariate* Estimated Odds Ratio for New Cases of Emphysema According
to Increments in Mean Ambient Levels of Air Pollutants (n = 6246; cases = 94).

Overall

Females

Males

OR (95% Cl)
(Genders combined)

OR (95% Cl)

OR (95% Cl)

Pollutant

Single Pollutant Model
PMio (pg/m3)
S02 (ppb)
N02 (ppb)
03 (ppb)

1.23
1.07
1.24
1.48

(1.06-1.43)
(1.01-1.22)
(1.05-1.47)
(1.06-2.07)

1.37 (1.11-1.69)
1.07 (0.99-1.15)
1.16 (0.93-1.45)
1.87(1.11-3.15)

1.10(0.08-1.37)
1.07 (0.99-1.15)
1.34 (1.04-1.73)
1.19(0.79-1.79)

Two Pollutant Model
PM io (pg/m3)
S02 (ppb)
PM io (pg/m3)
N02 (ppb)
PM io (pg/m3)
O3
(ppb)

1.21
1.05
1.18
1.16
1.17
1.21

(1.02-1.44)
(0.99-1.11)
(0.99-1.39)
(0.96-1.39)
(0.95-1.45)
(0.74-1.99)

1.29
1.04
1.16
1.13
1.28
1.41

1.11
1.02
1.12
1.01
1.08
1.09

(1.05-1.38)
(0.96-1.20)
(0.92-1.32)
(0.93-1.30)
(0.93-1.76)
(0.60-3.28)

(0.90-1.30)
(0.90-1.20)
(0.89-1.30)
(0.90-1.38)
(0.82-1.41)
(0.64-1.84)

*Adjusted for: Age, Sex, Education and Pack years smoking.
Abbreviations: PM 10= particles less than 10 pm; ppb = parts per billion; pg/m^micrograms per cubic
meter; Cl, 95% confidence interval; SE, standard error; OR, odds ratio.
OR for S02= exp (1 * (3); OR for PM|0, N02 and 03 = exp (10* P)
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Table 3.3 Multivariable* Estimated Odds Ratios of Emphysema Incidence Associated
with Each 40 days/year in Excess of 40, 60, 80 and 100pg/m3 of PMio. (n = 6246; cases =
94)
Pollutant
PMio(40pg/m3)¥

0.0024

S.E. (P)
0.0009

OR (95% Cl)
1.10(1.03-1.18)

PM,o(60|ug/m3)a

0.0025

0.0009

1.11 (1.03-1.19)

PM10(80pg/m3)a

0.0027

0.0010

1.11 (1.03-1.21)

PMio(100pg/m3)a

0.0030

0.0015

1.13 (1,00-1.27)

*Adjusted for: Age, Sex, Education and Pack years smoking.
Abbreviations: PM]0= particles less than 10 pm; pg/m3=micrograms per cubic meter; Cl, 95% confidence
interval; SE, standard error; OR, odds ratio.
aAverage annual hours in excess of 40, 60, 80 and 100 ppb.
OR for PM]o= exp (40* P)

43

Table 3.4 Pearson Correlation Coefficients for Selected Ambient Pollutants Mean
Concentrations for Years 1973-2000
Air pollutant
PM 10 (pg/m3)

N02 (ppb)
03 (ppb)
S02 (ppb)

PM10

no2

o3

so2

1.00
0.58**
0.74**
0.49**

1.00
0.32**
0.77**

1.00
0.27**

1.00

** p<0.01 level (2-tailed).
Abbreviations: PM ^particulates less than 10mm in aerodynamic diameter; ppb=parts per billion;
pg/m^micrograms per cubic meter
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Table 3.5 Multivariable* Estimated Odds Ratios of Emphysema Incidence Associated
with Each 40 Days/Year in Excess of 40, 60, 80 and lOOpg/m3 of PMio by Gender
(n=6246; cases=94).
Males

Females
Pollutant
PMjo
(40|ug/m3)a
PM10
(60pg/m3)a
PM10

(SOpg/m3)3
PM10
(100pg/m3)

Coefficient

S.E.

(R

OR (95% Cl)

0.0034

0.0013

1.15 (1.04-1.27)

0.0034

0.0012

1.15 (1.04-1.26)

0.0040

0.0013

1.17(1.06-1.30)

0.0052

0.0019

1.23 (1.06-1.43)

Coefficient

S.E.

OR (95% Cl)

0.0015

0.0013

1.06 (0.95-1.18)

0.0015

0.0012

1.06(0.97-1.17)

0.0012

0.0016

1.05 (0.93-1.19)

0.0001

0.0025

1.00(0.83-1.22)

a

*Adjusted for: Age, Education and smoke pack years.
Abbreviations: PM]0= particles less than 10 pm; pg/m3=micrograms per cubic meter; Cl, 95% confidence
interval; SE, standard error; OR, odds ratio.
aAverage annual hours in excess of 40, 60, 80 and 100 ppb.
OR for PM 10= exp (40* P)
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CHAPTER 4
SECOND PUBLISHABLE PAPER

Long-Term Ambient Ozone Concentrations and Incidence of Emphysema in
California Adults: Results from AHSMOG Study

Manuscript II, entitled “Long-Term Ambient PM 10 Concentrations and Incidence
of Emphysema in Population of California Adults” is prepared to describe the association
between prevalence of self-reported emphysema and PMio mean concentrations in the
Adventist Health and Smog study. The variables included for analysis include
emphysema as an outcome variable and age, gender, education and smoke pack years as
possible confounders. Logistic regression analysis using generalized model (GENMOD)
was performed to ascertain effect measure estimates.
The abstract was accepted in European Respiratory Society 2010 Annual
Congress, Abstract 2321 and in American College of Epidemiology, 2010, ACE-D-1000004. This manuscript is now being prepared for submission to a journal for
publication.

For Submission to: Chest Journal
*Note: The format and referencing style of this chapter is in accordance with journal
formatting guidelines as required by journal specifications and is not in accordance with
dissertation guidelines.
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ABSTRACT
The purpose of this study was to evaluate the relationship of long-term
concentrations of ambient ozone (O3) and risk of emphysema in California adults. A
cohort study of 6,338 non-Hispanic, white Californian adults, ages 27-95, was followed
from 1977 to 2000 for recently diagnosed emphysema. Monthly ambient air pollution
data were interpolated to ZIP-code centroids according to home and work location
histories and averaged over time. A 10 ppb increase in mean concentration of ozone was
associated with increased number of new emphysema cases with an OR of 1.48 (95% Cl:
1.06-2.07) after controlling for pack-years of past cigarette smoking, age and educational
level. In addition, we observed a significant association between incidence of
emphysema and each 10 days average annual increment of ozone in excess of 100, 120
and 150 (ppb) with OR of 1.13 (95% Cl: 1.03-1.23), 1.17 (95% Cl: 1.03-1.32), and 1.26
(95% Cl: 1.02-1.55), respectively. These risk estimates remained virtually unchanged in
two-pollutant models with PM 10. Our findings suggest that ambient air pollution levels,
especially ozone, are associated with development of emphysema in adults.

Key words: Ambient air pollution, emphysema, chronic obstructive pulmonary diseases,
COPD, particulate matter, ozone, sulfur dioxide, nitrogen dioxide.
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INTRODUCTION
Emphysema is the most common cause of death from respiratory disease in the
United States187. There are 1.8 million Americans with the disease, which ranks fifteenth
among chronic conditions that cause limitations of activity

. Emphysema is most

common among people aged 50 and older. Those with a genetic predisposition to
emphysema may experience the onset as early as their thirties or forties. Men are more
likely than women to develop emphysema, but female cases are increasing as the number
of female smokers rises187.
Emphysema is a chronic respiratory disease where there is over-inflation of the air
sacs (alveoli) in the lungs, causing a decrease in lung function and often
breathlessness 187,188 . Emphysema has a range of etiological factors. The association
between emphysema and cigarette smoking, repeated respiratory infections as a child and
alpha-antitrypsin deficiency are well established 188,189
Although little epidemiologic evidence exists to implicate air pollutants as a
contributing factor to the initiation and development of pulmonary emphysema, animal
studies suggest that chronic exposures to NO2 can initiate pre-emphysematous lung
changes. Compared to, for example, SO2 (which is soluble and readily absorbed by the
mucous membranes of the nose and respiratory tract), NO2 is less reactive in the upper
respiratory system and therefore passes into the pulmonary region, eventually reaching
the alveoli, where tissue damage can occur: hence, the potential for NO2 to cause
emphysema.
Ozone is a common summertime oxidizing pollutant produced by reactions of
ambient nitrogen oxides and volatile organic compounds in the presence of sunlight and
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heat190. In epidemiologic and field studies, exposure to ozone has been associated with a
range of health outcomes: increased daily mortality 84,191,192 , impaired lung function 193-195
as well as increased hospital admissions for respiratory disease

196-198

. A biological basis

for these responses has been provided by findings from animal 199,200 and human
laboratory-based studies 201-204 , where transient decrements in lung function, increased
hyperreactivity, and airway inflammation have all been demonstrated after exposure to
environmentally relevant concentrations of ozone 205-207
Epidemiologic studies have reported declines in respiratory function 194,195,208 and
increases in chronic respiratory illness 5,140,209,210 associated with increased exposure to
ambient ozone (O3). In addition, Beeson et al. found that elevated long-term ambient
concentrations of O3 were strongly associated with incidence of lung cancer141.
Although epidemiologic studies have reported that ambient levels of ozone are
associated with daily mortality, increased hospital admissions and decreased lung
function, to our knowledge the relationship between long-term ambient air pollution
levels (especially O3) and incidence of emphysema has not been studied. The purpose of
this paper is to study associations between incidence of emphysema and long-term
ambient concentrations of O3.
METHODS
Population
The enrollment and follow-up of the Adventist Health and Smog (AHSMOG)
cohort has been described in detail previously154. In summary, this is a cohort of 6,638
non-Hispanic adult white California Adventists who were part of the larger Adventist
Health Study (AHS-1) cohort155. To be included in the current study, subjects must: (a)
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have been residing for at least 10 years within 5 miles of their 1977 residence; (b) be a
resident of one of three metropolitan areas-San Francisco, the South Coast Air Basin, (i.e.
Los Angeles and eastward), or San Diego or be part of a 13% random sample of AHS-1
subjects who lived in the remainder of California; (c) be at least 25 years of age at the
time of completing the Adventist Census Questionnaire in 1974; (d) not be a current
smoker; and (e) be a baptized member of the Seventh-day Adventist (SDA) church at the
time of enrollment into the Adventist Health Study 140,154,156
Questionnaire
As part of the enrollment into the AHS-1, the AHSMOG participants completed a
detailed lifestyle questionnaire in 1976 consisting of demographic and anthropometric
data, exercise patterns, alcohol and tobacco consumption, occupation, current and past
dietary habits, parental history of cancer, and history of selected medical conditions 155.
In 1977, 1987, 1992 and 2000 the AHSMOG subjects completed mailed questionnaires
which included standardized respiratory symptoms questions derived from the American
Thoracic Society questionnaire 139,154,156 . In addition, based on these questionnaires,
month and year-specific residence and work address histories were updated for the time
period 1966 to 2000. The questionnaires also included lifestyle and housing
characteristics relevant to exposure to ambient air pollutants and indoor sources of air
pollutants. For deceased subjects, information was obtained from surrogates by
interviews (usually by telephone).
Air Pollution Estimates
Fixed site monitoring stations maintained by the California Air Resources Board
were utilized to estimate the monthly ambient concentrations of ozone (O3), sulfur
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dioxide (SO2), and nitrogen dioxide (N02)for study participants for the period 19732000. PM10 was not monitored directly in California until 1987. Thus, site- and seasonspecific regression equations based on total suspended particulates (TSP) were used to
estimate concentrations of PM10 prior to 1987154. The specific methods for estimating
ambient air pollutants for study subjects have been reported previously’ 139,140,156 . Briefly,
monthly indices of ambient air pollutant concentrations at 348 monitoring stations
throughout California were interpolated via Inverse Distance Weighting (IDW) to ZIPcode centroids of residence and work location histories of study subjects, cumulated, and
then averaged over time. Statistics from at most three of the nearest air monitoring
stations that satisfied the conditions of data representativeness were included in an
interpolation. The stations used in the IDW interpolation were weighted by 1/D , where
D was the distance from the station to the ZIP-code centroid. Interpolations were
restricted to ZIP-code centroids within 50 km (31.25 miles) of a monitoring station and
were not allowed to cross barriers to airflow or other topographic obstructions in excess
of 250 m above the surrounding terrain156.
Air quality monitoring stations needed to have "sufficiently complete data"
defined to be at least 10 months of representative data for one or more pollutants in each
of three or more years. For particulate pollution, which was monitored routinely for a 24
hour period every sixth day, representative data were defined to be at least four 24-hr
values in a month. For gaseous pollutants which were monitored hourly, a station must
have had at least 75% of the hourly values for the month to be considered representative.
Those station months that had less data for a pollutant were considered to have missing
data for that month and were not used for interpolation for that month.
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In addition to mean concentrations, exceedance concentrations in excess of
several cutoffs were estimated for O3 (with associations evaluated at increments of 10
days/year for each of the ozone exceedance cutoffs). Exceedance frequencies were
defined as the sum of days per year above a specified cutoff of O3. The cutoffs used for
O3 were 100, 120, and 150 parts per billion (ppb).
Definition of Health Outcomes
Study subjects were classified as having been diagnosed with emphysema if the
participants reported that they had been told by their physician that they had a diagnosis
of emphysema. Assessment of emphysema was done at the time of each of the mailed
questionnaires in 1977, 1987, 1992 and 2000.
Those who reported having a doctor told diagnosis of emphysema at baseline in
1977 were considered prevalent cases and excluded from this analysis. Participants were
considered as new cases if they did not report prevalent emphysema in 1977, but
indicated a doctor told emphysema diagnosis on any of the subsequent questionnaires in
1987, 1992 or 2000.
STATISTICAL ANALYSIS
Chi-square analysis was utilized to test the difference between baseline
demographic, personal and family characteristics of the cases and non-cases. Pearson
correlation coefficient was used to measure the association between pollutants.
Unconditional logistic regression analyses, using the generalized model (PROC
GENMOD in SAS statistical software) were used to evaluate the association between
mean concentration of O3, NO2, SO2 and PM10 and period incidence of emphysema as
well as to assess the association between exceedance frequencies of O3 and the incidence
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of emphysema. Type III Generalized Estimating Equations (GEE) were used to estimate
the Wald statistic, and hence statistical significance for each explanatory variable.
Associations between selected pollutants (O3, SO2, NO2 and PM10) and incidence of
emphysema were examined using both single and two-pollutant models. Overall average
annual mean ambient pollutant concentrations were utilized as ZIP-code specific fixed
measures of ambient air pollution exposure: 1973-1977 for emphysema cases identified
between 1977 and 1987; 1977-1987 for emphysema cases identified between 1987 and
1992; 1987-1992 for emphysema cases identified between 1992 and 2000. The non-case
comparison groups also were from the same respective time periods.
The period incidence of emphysema (1977-2000) was the dependent variable.
The air pollutants were initially studied one at a time controlling for selected variables in
a basic model which included age, gender, education and pack-years of past cigarette
smoking. In this cohort, education is the best estimator of social economic status.
Based on our research and review of the literature 137,139,150,159 , the following additional
variables were considered as potential covariates in the development of the final
statistical models: body mass index (BMI), history of allergies, total exercise, number of
homes within 1/4 mile radius of residence in 1977, outdoor vigorous exercise (hours per
week, including weekend), heavy physical labor, time spent outdoors (hours per week,
including weekend), years worked with a smoker, years lived with a smoker, occupation
with significant exposure to air pollutants, fruit intake, alcohol consumption, vegetarian
dietary pattern and antioxidant intake which could potentially predict incidence or could
act as effect modifiers of the emphysema incidence and O3 relationship. These variables
were added to the basic model one at a time to evaluate whether they changed the main
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•

•

effect of O3 on risk of incident emphysema by 10% or more

911

. However, none of the

potential covariates resulted in such a change. Thus the final model ultimately used to
assess risk of emphysema included: age, gender, education, pack-years of past cigarette
smoking and time period of case ascertainment as well as the pollutant under
investigation. Possible interactions were evaluated between O3, SO2, NO2, and PM10 and
outdoor exposure variables (outdoor vigorous exercise, heavy physical labor, time spent
outdoors, occupation with significant exposure to air pollutants)

128,157

with all covariates

(age, gender, education, smoke pack years) included in the final model. None of the
interaction terms significantly (p<0.05) improved the fit of the model and were thus
excluded from the final model.
Since air pollution components often appear together and are significantly
correlated (Table 4.1) and the association observed with O3 could be modified by other
air pollution components, we performed two-pollutant analyses where pairwise
comparison of O3 and mean concentration of PM10 were built-into the GENMOD models.
Pairwise comparisons were made on the fraction of the cohort having 80% non-missing
data for both pollutants. In addition, two-pollutant analyses were also performed for
exceedance frequencies of ozone (an increment of 10 days/year in excess of 100, 120 and
150 ppb) paired with mean concentrations of PM10.
RESULTS
Baseline characteristics of the study population are described in Table 4.2. Sixty
percent of the cohort lived in the South Coast Air Basin in 1977. Sixty-four percent of
the participants were female. Their ages in 1977 ranged from 27 to 95 years. Compared
to the non-cases, emphysema cases tended to be older, have lower educational levels,
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higher BMI and more years of past cigarette smoking, higher proportion with a history of
working in dusty environments and increased number of hours of vigorous exercise and
physical labor outdoors in the summer.
Mean concentration of O3 was significantly associated with odds of developing
emphysema with an OR of 1.48 (95% Cl: 1.06-2.07), controlling for pack-years of past
cigarette smoking, age, gender and educational level (Table 4.3). This association was
reduced and no longer significant in two pollutant models with the inclusion of PM10 with
an OR of 1.21 (Table 4.3).
When examining the effect of various levels of O3 using exceedance frequencies,
significant associations were observed between incidence of emphysema and each
increment of 10 days/year that O3 exceeded 100, 120 and 150 ppb with an OR of 1.13
(95% Cl: 1.03-1.23), 1.17 (95% Cl: 1.03-1.32) and 1.26 (95% Cl: 1.02-1.55),
respectively (Table 4.4). The regression coefficients (and thus OR’s) increased with
higher cutoffs of O3 exceedance frequencies, suggesting a “dose-response” effect (Table
4.4). When including PM10 in two-pollutant models, the OR of the various exceedance
frequencies for O3 cutoffs did not change significantly.
In addition to the ozone findings, we observed significant associations in the
single pollutant models between a 10 pg/m3 increase in mean concentration of PM 10, a 1
ppb increase in SO2 and a 10 ppb increase in NO2 and diagnosis of emphysema with an
OR of 1.07 (95% Cl: 1.01-1.22), 1.24 (95% Cl: 1.05-1.47) and 1.23 (95% Cl: 1.06-1.43)
respectively, controlling for pack-years of past cigarette smoking, gender, age and
educational level (Table 4.2). However, the association between incidence of
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emphysema and PMjo became non-significant when ozone was included in the two
pollutant model.
DISCUSSION
In this study, we have found long-term ambient concentrations of ozone to be
related to development of emphysema in the extended follow-up of the AHSMOG cohort
independent of age, gender, education and pack-years of past cigarette smoking. Our
findings are in line with previous findings from this cohort, with a shorter follow-up (i.e.
1977-1992), of associations between ozone and several respiratory disease
outcomes 5,140,141 , including incidence and severity of asthma5,212.
Risk of emphysema was also associated with each increment of 10 days/year in excess of
various exceedance frequencies of ozone (100, 120 and 150 ppb). These findings are in
line with previous reports of an association between exceedance frequencies of ozone
above 100 ppb and development of new cases of asthma and increase of severity of
asthma140.
In our review of the literature, we did not identify any published reports that
specifically addressed the long-term effects of ambient ozone on development of
emphysema. In fact, there are substantially more studies of long-term ambient ozone
concentration and mortality 84,191,192 and/or prevalence of respiratory symptoms 140,157,213
COPD153, asthma and bronchitis

5,194,210

than of incidence of respiratory diseases.

However, an increasing body of evidence has demonstrated that ozone is associated with
increases in mortality 84,192 and morbidity 5,140 from respiratory diseases both when ozone
is evaluated alone or in combination with other ambient air pollutants. Several studies
have reported an association between ambient ozone levels and increased hospital
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admissions due to respiratory problems 153,196-198,213 as well as declines in lung function 193195,198

. Our finding of an association between long-term concentration of ozone and

incidence of emphysema is consistent with these studies.
We found a positive relationship between ozone and development of emphysema
after adjusting for risk factors such as past cigarette smoking. This is consistent with
other studies which have looked at respiratory diseases including asthma, chronic
bronchitis, and respiratory symptoms (e.g. chronic phlegm, cough or both, wheeze and
breathlessness) 16,140,212,214,215
Overall, the results from our study are in line with previous epidemiological
studies supporting a positive adverse effect of exposure to ozone on respiratory health 192198,213,216

Possible Biologic Mechanisms
Much of the current understanding of the molecular targets of ozone comes from
extrapolating animal exposure models to potential human exposures 217-220 . Ozone has
been shown to react with polyunsaturated fatty acids and sulfhydryl amino acids and
some electron-rich compounds. Several types of reactions between ozone and these
elements are thought to occur and free radicals may be produced in the process 221-224
Ozone is an oxidant gas pollutant that can cause pulmonary fibrosis and changes in
epithelial populations at high exposures225. In addition, ozone produces free radicals,
lipid hydroperoxides, aldehydes, and hydrogen peroxide that can lead to cell damage

.

Ozone also causes pulmonary inflammation that peaks after a few days, but persists to a
much lesser degree for months in exposed rodents 226. These oxidative and inflammatory
properties may have emphysema-inducing effects 202,225-227
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Other studies have found that connective tissue components are directly degraded
by oxidants in vitro

208,228

. Exposure of animals to oxidant gases causes degradation of

lung connective tissue and results in an emphysematous lesion in the lung several weeks
after recovery

. Oxidant injury is also associated with an influx of inflammatory cells

which release proteolytic enzymes

. It is proposed that the emphysematous lesion

found after exposure to an oxidant gas is the result of two mechanisms causing
degradation of lung connective tissue; direct cleavage by free radicals and enzymatic
proteolysis 228-231 . It is possible that oxidant injury to the extracellular matrix is involved
in the pathogenesis of emphysema in humans since cigarette smoke contains an
exceedingly high concentration of oxidants 228-230 . Potential mechanisms for promotion of
emphysema may possibly include alterations of lung cytokines, degradation of lung
connective tissue and oxidative stress232.
Strengths and Limitations of the Study
This study has several strengths including a homogenous population of nonsmokers, thus eliminating the effect of residual confounding by active smoking. Also, we
have information on exposure to second-hand smoke and past smoking making it possible
to control for these as well.
The fact that the study is a prospective study with complete history of residence
and work location throughout the follow-up as well as the decade before enrollment
increases the validity of the ambient air pollution estimates for the individual subjects.
Also, the subjects were selected because they were less mobile and had lived within 5
miles of their 1977 baseline address since 1967. This also suggests less measurement

58

error in the ambient air pollution estimates and also makes it easier to follow up this less
mobile population.
Although we have shown respiratory effects of ambient ozone in this study, we
have unknown amounts of measurement error in both the estimated long-term ambient
concentrations of pollutants and other covariates. One source of measurement error
could be the interpolation of ambient concentrations of air pollutants (PMjo, O3, NO2,
SO2) from fixed site monitoring stations to ZIP-code centroids of study subjects’ work
and residence location and ultimately to the individuals themselves156. However, a
previous study of this cohort has shown that using these indirect estimates only
marginally impacts the precision of long term cumulative averages of PM 10 139
Another limitation of evaluating the relation between long-term O3 concentrations
and development of emphysema is that our estimates are not of personal exposures, but
outdoor ambient concentrations based on data from regional monitors 128,139 . It should be
pointed out, however, that legislation and policy making is based primarily on fixed site
monitored data rather than on personal exposures. We have attempted to control for the
lack of personal air pollution exposure measurements by including self-reported personal
exposure to past smoking, passive smoking, occupational exposure to dust and fumes, as
potential covariates in the health effects models. The results of using adjusted ambient
mean concentrations were consistent with those reported for unadjusted mean
concentrations.
In addition, because the outcome data are self-reported, study subjects may
underreport or overreport respiratory symptoms and diseases. However, this would most
likely be non-differential misclassification resulting in an underestimation of the true
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association. Despite this possibility, we still found significant associations between
ambient ozone levels and self-reported emphysema.
SUMMARY
Our results indicate that long-term ambient O3 levels are associated with
increased incidence of emphysema. In addition, a significant positive association was
found between incidence of emphysema and each increment of 10 days/year that O3
exceeded several cutoff points. The O3 regression estimates increased as the density of
the O3 in the ambient air increased.
Our findings of association between ambient O3 levels and respiratory disease are
in agreement with those from other studies. Further research from larger cohorts and
with better assessment of exposure and outcome are needed to better understand the
association between O3 and incidence of emphysema.
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Table 4.1 Pearson Correlation Coefficients for Selected Ambient Pollutants Mean
Concentrations Averaged for Years 1973-2000.
Air pollutant
PM,0 (gg/m3)

PMiq (gg/m3)

1.00
0.58**

NO2 (ppb)
03 (ppb)

0.74**

S02 (ppb)_________

0.49**

N02 (ppb)

O3 (ppb)

S02 (ppb)

1.00
0.32**
0.77**

1.00
0.27**

1.00

** p<0.01 level (2-tailed).
Definition of abbreviation: PM10: Inhalable particulates less than 10mm in aerodynamic diameter;
ppb=Parts per billion; pg/m3=micrograms per cubic meter
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Table 4.2 Distributions of Selected Variables in the AHSMOG Study According
to Noncases and Cases of Incident Emphysema.
Emphysema
Variables
Age in 1977 **
< 25-50 Years Old
50-59 Years Old
60-69 Years Old
70 or Older
Gender
Females
Males
BMI
<25 kg/m2
25.0-29.9 kg/m2
>=30 kg/m2
Education
High School Diploma or Less
Some College
College/ Graduate Degree
Diet
Vegetarian t
Non-vegetarian
Current alcohol use
No
Yes
Multi vitamin & vitamin A, C and E supplement
No high vitamin intake
High on at least one of the
vitamin pills
Total exercise
None or light exercise
Mild
Moderate
Vigorous
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Cases
(n = 94)

Non-cases
(n =6246)

%

%

14.0

29.0
39.8

26.0
25.2
25.4

17.2

23.4

51.0
49.0

64.0
36.0

54.1
30.6
15.3

31.3
10.3

40.9
41.9
17.2

57.0
43.0

87.9
12.1

52.7
45.2

58.4

35.2
39.0
25.8
51.7
48.3
92.0
8.0
51.0
44.2

27.2
13.0

29.6

16.3
43.5

20.5
38.6

11.3

Table 4.2 (Continued) Distributions of Selected Variables in the AHSMOG
Study According to Noncases and Cases of Incident Emphysema.
Emphysema
Non-cases
Cases
(n =6246)
(n = 94)

Variables
Allergies
None/Not Reported
Reported
Job Air pollution *
No
Yes
No. of homes within % radius of residence
<5

5-10
> 10
Hours vigorous exercise & physical labor
outdoors in summer
None
1-14 hours/Week
>=15 hours/Week
Hours outdoor in summer
None
1-14 hours/Week
>=15 hours/Week
Smoke pack years **
Never
1-20 Pack Years
>=21 Pack Years

%

%

51.1
48.9

56.5
43.5

89.2
10.8

94.5

3.3
5.5

4.1
10.1
85.8

5.5

91.2

25.0

63.0
12.0

22.3
70.7
7.0

1.1

2.5

77.2

77.1

21.7

20.4

28.1
25.0

44.7
34.2

46.9

21.0

*p-Value for chi-square test comparing distributions of cases to noncases <0.05
**/?-Value for chi-square test comparing distributions of cases to noncases <0.01
+ Vegetarian if meat intake none or < 1 time/week. Non-vegetarian, if meat intake >:=l/week.
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Table 4.3 Multivariate1 Estimated Odds Ratio for New Cases of Emphysema (19772000) According to Increments in Mean Ambient Levels of Air Pollutants (n = 6246;
cases = 94).
Pollutant
One Pollutant Model
03 (ppb)
S02 (ppb)
N02 (ppb)
PMiq (pg/m3)
Two Pollutant Model
03 (ppb)

PM]0 (pg/m3)

Coefficient (P)

S.E (P)

OR2 (95% Cl)

0.0393
0.0633
0.0217
0.0205

0.0171
0.0263
0.0087
0.0077

1.48 (1.06-2.07)
1.07 (1.01-1.22)
1.24(1.05-1.47)
1.23 (1.06-1.43)

0.0194
0.0159

0.0253
0.0107

1.21 (0.74-1.99)
1.17 (0.95-1.45)

Adjusted for: Age, Gender, Education and Pack years of smoking
2 Odds ratio
Abbreviations: PM]0= particles less than 10 pm in aerodynamic diameter; ppb = parts per billion;
|ug/m3=micrograms per cubic meter
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Table 4.4 Multivariable1 Estimated Odds Ratios of Emphysema Incidence Associated
with Each 10 Days/Year in Excess of 100, 120 and 150 ppb of Ozone (n = 6246; cases =
94).
Pollutant
O3 (100 ppb)
O3 (120 ppb)
03 (150 ppb)

0.0120
0.0153
0.0231

S.E. (P)
0.0045
0.0062
0.0106

OR2 (95% Cl)
1.13 (1.03-1.23)
1.17 (1.03-1.32)
1.26 (1.02-1.55)

Adjusted for: Age, Gender, Education and Pack years smoking.
2 Odds ratio
Abbreviations: 03, ozone ppb, Parts per billion; Cl, 95% confidence interval; SE, standard error.
OR for 03 = exp (10*p) ’

65

CHAPTER 5
ADDITIONAL FINDINGS

This chapter presents additional findings using Adventist Health and Smog data to
describe the association between PMio and incidence of asthma. The outcome variable
was incidence of asthma (1977-2000). The primary exposure variable was PMio mean
concentration from 1973 to 1977. Body mass index (BMI), history of allergies, total
exercise, number of homes within 1/4 mile radius of residence in 1977, outdoor vigorous
exercise, time spent outdoors, years worked with a smoker, years lived with a smoker,
occupation with significant exposure to air pollutants, fruit intake, alcohol consumption,
vegetarian dietary pattern and antioxidant intake were also included in the models as
possible confounders. Unconditional logistic regression analysis was conducted to
determine effect measure estimates.
A. Objective
To evaluate whether an association existed between long-term concentrations of
ambient PMio and risk of asthma in California adults, analyses was performed using data
from the Adventist Health and Smog study.
B. Methods
1. Population
This is a cohort of 6,338 nonsmoking, non-Hispanic adult white California
Adventists who were part of the larger Adventist Health Study (AHS-1) cohort154. As
part of the enrollment into the AHS-1, the AHSMOG participants completed a detailed
lifestyle questionnaire in 1976
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consisting of demographics, anthropometries data, exercise patterns, alcohol and tobacco
consumption, occupation, current and past dietary habits, parental history of cancer, and
history of selected medical conditions155. In 1977, 1987, 1992 and 2000 the AHSMOG
subjects completed mailed questionnaires which included standardized respiratory
symptoms questions derived from the American Thoracic Society questionnaire 155. In
addition, based on these questionnaires, residence and work address histories were
updated for the time period 1966 to 2000 or until date of death 154-156 . The questionnaires
also included lifestyle and housing characteristics relevant to exposure to ambient air
pollutants and indoor sources of air pollutants. For deceased subjects, information was
obtained from surrogates by interviews (usually telephone).
2. Air Pollution Estimates
PMio was not monitored directly in California until 1987. Thus, site- and
season-specific regression equations based on total suspended particulates (TSP) were
used to estimate concentrations of PMio prior to 1987154. Monthly indices of ambient air
pollutant concentrations at 348 monitoring stations throughout California were
interpolated to zip code centroids based on home and work location histories of study
subjects, cumulated, and then averaged over time. Interpolations were restricted to zip
code centroids within 50 km (31.25 miles) of a monitoring station and were not allowed
to cross barriers to airflow or other topographic obstructions in excess of 250 m above the
surrounding terrain156.
3. Definition of Health Outcomes
Study subjects were classified as having been diagnosed with asthma if the
participants reported that they had been told by their physician that they had a diagnosis of
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asthma. Assessment of asthma was done at the time of each of the mailed questionnaires
in 1977, 1987, 1992 and 2000.
Those who reported having a doctor told diagnosis of asthma at baseline in 1977
were considered prevalent cases and excluded from this analysis. Participants were
considered as new cases if they did not report prevalent asthma in 1977, but indicated a
doctor told asthma diagnosis on any of the subsequent questionnaires in 1987, 1992 or
2000.

C. Statistical Analysis
Differences in baseline characteristics were evaluated using chi-square test.
Pearson correlation coefficient was used to measure the association between pollutants.
Unconditional logistic regression analysis was then used to determine odds ratios (OR)
and the corresponding 95 percent confidence interval (Cl) for associations between mean
concentration of PMio and incidence of asthma. Based on our research and review of the
literature 137,139,150,159 , the following additional variables were considered as potential
covariates in the development of the final statistical models: body mass index (BMI),
history of allergies, total exercise, number of homes within 1/4 mile radius of residence in
1977, outdoor vigorous exercise (hours per week, including weekend), heavy physical
labor, time spent outdoors (hours per week, including weekend), years worked with a
smoker, years lived with a smoker, occupation with significant exposure to air pollutants,
fruit intake, alcohol consumption, vegetarian dietary pattern and antioxidant intake which
could potentially predict incidence or act as effect modifiers of the asthma incidence and
PMio relationship. Any factor whose inclusion changed the main effect of PMio for
asthma by 10% or more was retained as a covariate in the final model21 ^ None of the
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potential covariates other than those in the final model changed the main effect by 10%
or more. Thus, the final model ultimately used to assess risk of asthma included age,
gender, education and pack-years of cigarette smoking as well as the pollutant under
investigation.
D. Results
Sixty percent of the cohort lived in the South Coast Air Basin in 1977. Sixtyfour percent of the participants were female. Their ages in 1977 ranged from 27 to 95
years (mean= 56.2). Baseline characteristics of the study population are described in
Table 5.1. Compared to the non-cases, asthma cases tended to be younger had higher
educational levels, higher BMI, higher proportion with allergies, higher proportion with a
history of increased number of hours of vigorous exercise and physical labor outdoors in
the summer. None of these differences were statistically significant except for age,
education and allergy distributions.
The multivariate odds ratio (OR) with 95 percent confidence interval (Cl) relating
mean concentration of PMio (1973-1977) to incidence of asthma are shown in Table 5.2.
We did not observe any association between mean concentration of PMio and risk of
developing asthma, controlling for pack-years of past cigarette smoking, age and
educational level. In addition, the OR of PMio did not change significantly when the
mean concentrations of O3, SO2, and NO2 were included in two pollutant models (Table
5.2).
E. Summary
Our results were not conclusive in evaluating the association of mean
concentration of PMio and risk of developing asthma. Further research with longer
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follow-up time and better assessment of exposure and outcome are needed to better
understand the association between PMjo and incidence of asthma.
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Table 5.1 Distributions of Selected Variables in the AHSMOG Study According
to Noncases and Cases of Incident Asthma
Asthma
Percent
non-cases
(n =6184 )

Variables
Age in 1977
25.1*
<50 Years Old
25.2
50-59 Years Old
25.7
60-69 Years Old
24.0
70 or Older
BMI
58.9
<25
31.2
25.0-29.9
9.8
>=30
Education
35.9*
High School Diploma or Less
38.6
Some College
25.5
College/ Graduate Degree
Current alcohol use
92.0
No
8.0
Yes
Job Air pollution
94.2*
No
5.8
Yes
No. of homes within % radius of residence
4.2
< 5 Miles
10.0
5-10 Miles
85.8
> 10 Miles
Hours outdoor in summer
2.3
None
64.3
1-14 hours/Week
33.3
>=15 hours/Week
Smoke pack years
44.3
Never
34.5
1-120 Pack Years
21.2
>=21 Pack Years
Years worked with smoker
58.8
Never
22.7
1-10 Years
18.5
>=11 Years
Years lived with smoker
57.5
Never
12.9
1-10 Years
29.7
>=11 Years
*p-Value for chi-square test comparing distributions of cases to noncases <0.05
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Percent
cases
(n =154 )
42.2

27.9
22.1
7.8
54.5
35.7
9.8
21.7
46.7
31.6
93.9
6.1
98.1
1.9
5.9
7.9
86.2
1.3
64.1
34.6
50.0
42.3
7.7

51.9
25.3
22.7

55.8
11.0
33.1

Table 5.2 Multivariate* Odds Ratio for New Cases of Asthma According to Increments
in Mean Ambient Levels of Air Pollutants (n = 6184; cases = 154).
Pollutant
One Pollutant Model
PMio (|ag/m3)
03 (ppb)
S02 (ppb)
NO2 (ppb)
Two Pollutant Model
PM10 (pg/m3)
03 (ppb)
PM10 (pg/m3)
S02 (ppb)
PM 10 (pg/m3)

S.E (P)

OR (95% Cl)

0.006
0.017
0.012
0.006

0.005
0.013
0.018
0.005

1.06
1.18
0.97
1.06

(0.96-1.17)
(0.92-1.53)
(0.97-1.05)
(0.96-1.17)

0.002
0.015
0.009
0.022
0.008
0.009

0.007
0.017
0.006
0.019
0.006
0.006

1.02
1.16
1.09
1.02
1.08
1.09

(0.89-1.17)
(0.83-1.62)
(0.97-1.23)
(0.99-1.06)
(0.96-1.22)
(0.97-1.23)

Coefficient (P)

NO2 (ppb)
* Adjusted for: Age, Sex, Education and Pack years smoking.
Abbreviations: PMi0= particles less than 10 pm; ppb = parts per billion; Cl, 95% confidence interval; SE,
standard error; OR=Odds ratio..
OR for S02= exp (1* P); OR for PM)0j N02and 03= exp (10* P)
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CHAPTER 6
CONCLUSIONS

A. Summary
The purpose of this dissertation was to evaluate the association between long-term
ambient air pollution levels and risk of emphysema in nonsmoking California adults.
Studies conducted over the past 15 years have provided substantial evidence that long
term exposure to air pollution is a risk factor for cardiopulmonary disease.
Although COPD mortality has been studied extensively in the past 20 years, to
our knowledge, the relationship between long-term ambient air pollution (especially
PM io and O3) and incidence of emphysema has not been explored using large
epidemiological studies. The author used a large-scale epidemiological study that had
self-reported information on demographic characteristics, dietary pattern, doctor told
emphysema diagnosis and several other variables. Analyses were conducted separately
for men and women and the associations were explored between mean concentrations of
PM 10 and ozone and period incidence of emphysema and incorporated the frequently
cited confounding variables in a logistic regression model. This objective was met and
was presented in chapters 3 and 4.
B. Main Findings
Our data suggest that long-term exposure to ambient PM 10 is associated with
increased incidence of emphysema in females, but not in males. The observed
association remained after adjusting for relevant confounders, including pack-years of
past smoking, and after adjusting for O3 in two-pollutant models. Further, a significant
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positive association was found between incidence of emphysema and each increment of
40 days/year that PMio exceeded several cutoff points.
A similar association was also observed for long-term exposure to ambient O3 and
incidence of emphysema. The association remained after adjusting for relevant
confounders, including age and pack-years of past smoking and after adjusting for PM 10
in two-pollutant models. In addition, a significant positive association was found
between incidence of emphysema and each increment of 10 days/year that O3 exceeded
several cutoff points.
The results from this dissertation support the hypothesis of a positive association
between long-term exposure to ambient air pollution and emphysema and are in
agreement with those from other studies.
C. Strengths and Limitations of the Studies
The study has several strengths including a homogenous population of nonsmokers, thus eliminating the effect of residual confounding by active smoking. Also, we
have information on exposure to second-hand smoke and past smoking making it possible
to control for these as well. The fact that the study is a prospective cohort study with
complete history of residence and work location throughout the follow-up increases the
validity of the ambient air pollution estimates for the individual subjects. Also, the
subjects were selected because they were less mobile and had lived within 5 miles of
their 1977 baseline address since 1967. This also assures better ambient air pollution
estimates and also makes it easier to follow up this less mobile population.
Although we have shown respiratory effects of particulate air pollution in this
study, we have unknown amounts of measurement error in both the estimated long-term
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ambient concentrations of pollutants and other covariates. One source of measurement
error could be interpolating ambient concentrations (PMio, O3, NO2, SO2) from fixed site
monitoring stations to zip code centroids of study subjects’ work and residence locations.
Another source of measurement error is using indirect estimates of PM10 before 1987.
However, a previous study of this cohort has shown that using these indirect estimates
only marginally impacts the precision of long term cumulative averages of PM 10

.

Another limitation of evaluating the relation between long-term PM 10 and ozone
concentrations and development of emphysema is that our estimates are not of personal
exposures but outdoor ambient concentrations based on data from regional monitors. We
have attempted to control for the lack of personal air pollution exposure measurements by
using self-reported personal exposure to past personal smoking, passive smoking,
occupational exposures to dusts and fumes, as covariates in the health effects models.
In addition, the outcome data obtained for our studies were self-reported.
Accurate evaluation of outcome information using self-reported data has been a challenge
to epidemiological studies. Temporal relationship cannot be easily ascertained from such
a comprehensive epidemiological study, and suggesting a biological explanation is not
the objective of this dissertation. However, the findings from this dissertation, along
with available findings from other epidemiological studies and basic science reports seem
to provide evidence supporting the hypothesis upon which this dissertation is based.
D. Future Research
It is hoped that this dissertation be informative in identifying new areas for further
research. Two areas were prominent during the process of this dissertation and are
described below.
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Understanding the epidemiology of the air pollution and different forms of COPD
requires accurate and consistent identification of the specific forms of COPD. The
difficulty is that available studies used self-reported data and different case definitions.
This reality emphasizes the need for a case validation study and development of a
standard protocol for epidemiological case ascertainment. Until such a protocol is
established, interpretation of research findings and comparison to one another will remain
challenging.
Our findings of a gender difference in the association between ambient air
pollution and respiratory disease are in agreement with those from other studies. Further
research from larger cohorts and with better assessment of exposure and outcome are
needed to better understand the association between PMio, ozone and incidence of
emphysema as well as the gender difference observed.
Given the results from this study it would be valuable to carry out new studies
from larger population to further investigate possible associations between ambient air
pollution and emphysema incidence.
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APPENDIX A: RESPIRATORY SYMPTOMS AND RESIDENCE HISTORY
QUESTIONNAIRE 1977

LOMA LINDA UNIVERSITY

i-pj

LOMA LIKDA, CAUrOP.N'lX 92534
(714) 795-7511 5X7. 3717

SCHOOL OF HSALTK
AD'.'J.N'TiST K3ALTK STU07

Dear Friend:
Youare one of a small group selected from all participants In the'
Adventist .Health Study to help in a special substudy. This substudy
1s sponsored by the Air Resources Board to measure some effects of-'
the type of air you breathe.
We have greatly appreciated your cooperation and efforts in completina'.
the detailed lifestyle questionnaire which is helping us to determine"
the possible relaiionship between various aspects of lifestyle and
health status. The enclosed questionnaire will supplement this infor
mation with some additional questions.
Most other members in your church are receiving only the back page
of this questionnaire which is the first of the yesrlv hospital history
forms being sent to all adult SDAs in California. It"is extremely
important for you to complete this last page because it is our only
means of keeping track of^the health status of California SDAs. The
jew minutes necessary to fill in the entire questionnaire will contri
bute signi ficantly to new knowledge that may save many lives.
Sy^completing this questionnaire NOW, you will save us the expense and
effort of having to contact you personally. Please return the completed
questionnaire in the enclosed self-addressed envelop. Thank you for
your assistance.
Sincerely yours,

Roland.L. Phillips, M.Q.
Director
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RESPIRATORY SYMPTOM'S AND RESIDENCE
HISTORY QUESTIONNAIRE
•Plsisa answer every question.
WHEEZING
9. Does your breathing ever sound
wheezy or whistling?
1 C 3 Yes
2 L ] No

COUGH
1. Do you usually cough first thing in
the morning?

1 C D Ye3

» L J No
2.

10.

Do you usually cough at other times
during-the day. or'night?
1 C 3 Yes

2 C 3 No
3.

Do you cough on most days for 3 months
or more?
1 c 3 Yes
* 3 3 no

4.

For how many years have you had a
cough?
• f 1 Never
2 L J Less than I year
2 C 3 More then ! but less then
2 years
^ C 3 2-5 years
s C 3 More then 5 years

* .

BREATHLESSNESS
1-1- Are you troubled by shortness of
breath when hurrying on level
ground or walkina yo e slight,
hill?

1 C 3.Yes
2 r 3 no
12

SPUTUM
5. Do you usually bring up phlegm,
sputum, or mucus from your chest
first thing in the morning?
C 3 Yes
2 : S’ No
6.

• 7.

8.

Have you ever had attacks of
shortness of breath with wheezing?
J C 3 Yes '
2 3 I1 No

Do you get short of breath when
walking at a normal pace with
other people of ycur own age on
level ground?
1 C 3 Yes
z 1 3 No

RESPIRATORY ILLNESS
13. During the PAST YEAR, how often,
were you unable to do your usual
.activities because of illnesses
such as chest coles, bronchitis,
or pneumonia?'
1 C D None
2f 3 r 'time
3 C 3. 2-5 times
4 C 3 Mors than 5 times

Dc you usually bring up phlegm,
sputum, or mucus from your chest at
other times during the day or night?
1 C 3 Yes
2 £ 3" Me

14.

Do you bring up phlegm, sputum or
mucus from your chest on most days
for 3 months of the year or more?
i
C J Yes
2 £ 3 Nc

Do you think you have.ever had any
of these chest disorders—asthma,
any kind of bronchi a 1 condition,or emphysema?
' * £ i Yes

2 C 3 No

For how many years have you raised
phlegm, sputum, or-mucus from your
chest?
1 £' 3 Never
2 L T Less then J yeer
2 C 3 More then I but less then
2 years

15.

, £L 33 More
2-5 y”rs
than 5 years
PLEASE GO TO TOP OF NEXT.COLUMN.

1
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Has a doctor ever told you that
you had asthma, sons kind of
-bronchiaT condition, or emphysema?
2C 3 No
IF YES, pi ease.check £/j
which conditions.
2C 3 Asthma
ur
j. 3 Sronch i a I ccr.c i t i on
E L J Emphysema

25.

16. How many days per month during the
SUMMER (June thru'September) are you
bothered by stuffy nose or post-nasal
drip (i.e. drainage from.the back of
your nose into your throat)'?

Are you usually away from home for' "
more than 2 weeks during the.summer
(June thru September)?
’E ] No
> Yes

C D None

ZC 3 1-5 days

26.

-J 6-10 days
'£ D I 1-20 days
C D 2! days or core

IF YtS, hovf long are you usually away?
1C 1 3-4 weeks

17. How many days per month during the
WINTER (October thru May) are you
bothered by stuffy nose or post-nasal
drip (i .e./drainage from the back of
your nose into your throat)?

2C 3 5-6 weeks
5 E '3 7-8 weeks

"n N°he

^ C 3 9 weeks or more.

3 1-5 days
3E J 6-10 days
“C 3 11-20 days
5C J 21 days or more

27.

-/e you EVER regularly smoked cigarettes,
oes,. or cigars (aside from possibly
/ing them once or twice)?.
, Yes
No
18.
-Q
C 3
' Cigarettes

>'€' HI 3-

C'l

j

E 3
3
5C 3
V E -3
5C J
* f j
7E 3
1 E 3

Pipes .

20.
SC 3 sE -j'
Cigars '
'ing the PAST YEAR, how many times have
j had the following illnesses? (Please
;ck Tvg the appropriate box for EACH
• i:
•) .

28-

21. Head cold (e.g. runny nose, sere
throat, etc.)
None I
2
3 or more
22. Chest cold (acute bronchitis e.g;
cough and sputum associated with
, .respiratory infection)
1

2

3 or more

T 3 lr i 2c i Jc 3

22. Pneumonia
None 1

2S •
2

°C J lC 3

3 or mors

3JC 3

2

Oh a typical WEEKEND, hew many hours
per day do you spend driving or
riding on.CROWDED roadways? (Check
the nearest category.)
.

How often do you use aerosol sprays
(e.g. hair spray, cleaning spray,
deodorant, spray paint, etc.)?
’‘t-J Daily
*C 3 Several times a week
3[ 3 Once a week
''[la few times a month
5E 3'Rarely or never

24. Hov/ many times was this pneumonia
diagnosed by a physician using a
chest x-ray?
None

None
Lees than 15 minutes
15 minutes to one hour
2 hours
3 hours
4 hours
5 hours
b hours or more

*£ 3 None
*£ 1 Less then 15 minutes
3 1 5-29 mi nutss
“t 3 3C-59 minutes
. SC 3 1-2 hours
“C 3 5-4 hours
^ 3 5-6 hours
8C 3 6 hours or more

°C ] lC 3 zr 1 3C 3

None

How many hours per DAY during the
work week do you usually spend
driving or riding on CROWDED roadways?
(Chsck'the nearest category.)'

3 or mere

T J ^ 3 :C 3 JC 3

30.

What is your usual or main occupation?
(Do riot write "retired". If retired
)r not now working, give your usual ,
iccupation when you were work!no.)
Job Title^__ ______ ______ ______ ,
Major duties or responsibilities: •

PLEASE GO TO TOP OF NEXT COLUMN.

2
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31.
SUKHES
(June thru September)
How many hours per WEEK, includina weekends > HI 3 Nona
do you exercise vigorously or do heevy
% 3 1-7 hours
physical labor(e.g. jogging, tennis,
3C 3 e-14 hours
gardening, etc.) in the open air?
T 3 15-21 hours
^ 3 22-28 hours
sc 3 29-35 hours
T 3 36-42 hours
*C 3 Mora than 42 hours
SUMMER '
33
(June thru September)
How many hours per WEEK, including weekends, ‘C 3 None'
ore you outside of, Buil’dings?
C J It7 hours
C 3 8-14' hours
H 3 15-21 hours
H 3 Z2-2S hours
C 3 29-35 hours
C j 36-42 hours
1 3 More then 42 hours
35..

Have you ever lived for one year or more with someone who smoked?
3 No
’ L J. Yes ------7 How many years?

36.

Have you worked in the .same room, with someone who smoked?

• '32.

REST OF YEAR
(Octoter thru Hey)
lC 3 Nona
J 1-7 hours
]C J 6-14 hours
“C J 15-21 hours
5C 3 22-26 hours
*C J 29-35 hours
7C 3 36-42 hours
3C 3 More than 42 hours
‘ 3^r. t REST. OF YEAR
(October thru Hey)
C 3 None
K 3 1-7 hours .
^ 3 6-14 hours
ju.'3 13-21 hours
’L 3 22-2S hours
SL 3 23-33 hours
T 3 36-42 hours
*C 3.More than 42 hours

’p 3 No

C .. Yss

Hov/ many years?

37.- Have you ever worked where you were exposed much of the time to various types of
_oni.aminated sir such as chemical fumes, paint fumes, welding, .wood or rock dust, etc.

°C I No
C ] Yss

T~

9

How many years?

IF YES. please list:
38. Type of work________
39. Type of contamination

if you have worked more than 5 miles from home in the past 10 years, please give the work locations
and dates
Started Job:
MONTH
YEAR

Ended Job:
MONTH YEAR

TOWN OF WORK

4C.
43.'.
42.
43. ’
44.
4r-
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•

STATE

ZIP CODE
PLACE OF WORK

UNIVERSITY LIBRARIES
LOMA LINDA, CALIFORNIA
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